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Abstract 
American Indian and Alaska Natives are burdened by a higher incidence of chronic 
diseases than non-Native populations. In an effort to improve the health status of its 
patients, the Ukudigaunal Wellness Center (UWC) partnered with the Improving Patient 
Care (IPC) Collaborative to implement changes designed to improve chronic disease care 
for Native Alaskans through intensive monitoring of screening for chronic disease and 
selected chronic disease outcomes. For this program evaluation, the units of analysis were 
the changes in health service delivery and the resulting patient clinical outcomes. The 
data source was the Registration and Patient Management System (RPMS), repository for 
the data collected over the 14 months of the collaborative. This system produced 
Shewhart run charts to show the percentage screening rates for patients achieving IPC 
processes and outcome measures. The findings showed that the process measures that 
met IPC goals were due to improvements in service delivery by UWC. Goals for other 
services, such as diagnostic screenings, were not met because these clinical components 
had to be coordinated with facilities outside UWC. Outcome measures for BP and 
HgbA1c control were not met as these depended on the patients’ abilities to self-manage 
the required procedures. The implications for social change included: (a) Positive 
outcome in managing chronic diseases is possible by combining chronic care models with 
Deming’s model for improvement; (b) Increased patient awareness of chronic conditions 
and their long term consequences tended to support more responsible and successful 
patient self-management; (c) Use of external medical resources should be considered 
when patient privacy and confidentiality are concerns. 
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Chapter 1: Introduction to the Study  
Chronic Disease Significance 
Providing quality health care for individuals with chronic disease is important to 
prevent complications and progression.  Many researchers emphasize the importance of 
providing quality care, but maintain that some providers are not fulfilling this mandate.  
Patients are not getting recommended preventive screenings, are not receiving adequate 
medications for their chronic condition and are not meeting recommended target goals for 
their chronic condition (Cohen, Clark et al., 2004; Clark et.al., 2011; Wagner et al., 
2001).  Providing quality care for chronic disease is important for many reasons such as 
decreasing the cost of health care, decreasing the impact on the health care system in 
terms of patient volume, and for improving patient outcomes.   
Chronic disease is a significant burden on the health care system in the United 
States.  Chronic disease is defined as a health condition that persists over a long period 
(Wagner, Austin, & VonKorff, 1996).    Chronic disease may be progressive and 
disabling and result in decreased quality of life and cause early death.  The top chronic 
diseases include diabetes, hypertension, cancer, asthma, stroke, heart disease, and lung 
disease (CDC, 2012).  About 40% of the U.S. population has a chronic disease, and 21% 
have more than one chronic disease (Anderson & Horvath, 2004).  These reports and 
studies support the need for programs to improve chronic disease care.  Additionally, 
chronic disease stresses the health care system in terms of patient volume. 
The large number of individuals with chronic conditions tests the capacity of the 
health care system.  Individuals with chronic disease use the health care system at a much 
2 
 
higher rate than the rest of the population (Anderson & Horvath, 2004).  Not only do 
chronic diseases stress the health care system, they are also the leading causes of both 
disability and death in the United States (Anderson & Horvath, 2004; Centers for Disease 
Control, 2012).  According to the Centers for Disease Control (2007, 2008), 25.8 million 
individuals live with diabetes, which is the leading cause of kidney failure, non-traumatic 
lower-extremity amputations, and blindness among adults.  In addition, the Centers for 
Disease Control (2011) stated that about 60% of individuals with diabetes have some 
form of nervous system damage.  An estimated 30% of the U.S. population has one or 
more form of cardiovascular disease (Bertoia, Waring, Supta, Roberts, & Eaton, 2012; 
Mensah & Brown, 2007).  The studies mentioned above demonstrate the large scope of 
chronic diseases and thus the need for additional studies to investigate ways to prevent 
chronic disease and to prevent complications for individuals with chronic disease. 
In addition to increased morbidity and mortality, patients with chronic disease 
also experience decreased job productivity and a decreased quality of life (Bertoia, 2012; 
Mokdad, Marks, Stroup, & Gerberding, 2004).  Alvere Health (2007) found that for every 
1,000 individuals with asthma, diabetes, and hypertension, 1,221 work days are lost each 
year.  Asthma accounts for 8 million work days lost each year (Goetzel et al., 2004).  The 
financial cost to the U.S. economy due to worker absenteeism and decreased productivity 
from chronic disease was estimated to be over $1 trillion in 2003 (DeVol & Bedroussian, 
2007).   Work productivity and days lost to chronic disease could be improved by better 
management of chronic disease.  In addition to lost productivity and days lost, chronic 
disease also has financial consequences. 
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Chronic disease also is a financial drain on the health care system in the United 
States.  About 78% of health care spending in the United States is used to treat chronic 
disease (Anderson & Horvath, 2004).  According to the American Diabetes Association 
(2011), diabetes costs amounted to $174 billion in the United States in 2007.  If the costs 
of gestational diabetes, undiagnosed diabetes, and prediabetes are also factored in, then 
the cost goes up to a $218 billion (author, year).  Heart disease and stroke also have high 
costs.  The outlay for heart disease and stroke care is $432 billion a year in the United 
States (Mensah & Brown, 2007).  Lung disease also has significant financial cost to the 
health care system.  It is estimated that lung disease costs amount to $154 billion each 
year in the United States (National Heart, Lung and Blood Institute, 2004).  By 2023, 
experts estimate that the total cost of caring for chronic disease will exceed $1.6 trillion 
(DeVol & Bedroussian, 2007).  As chronic diseases increase it is reasonable to expect 
that the cost of caring for chronic disease will also increase.  This increase is yet another 
reason that supports the need for improvement in chronic disease care.   
Alaska Native Disparities 
Chronic diseases occur in all populations, but some groups are impacted by 
chronic disease to a greater extent.  A disparity in chronic diseases exists between the 
overall U.S. population and Native American people (Acton et al., 2002; Amparo, Far, & 
Dietz, 2011; Indian Health Service [IHS], 2013; Sequist et al., 2010).  Particularly Type 2 
diabetes is more prevalent among Native American people than all other racial groups in 
the United States (IHS, 2013).  Diabetes prevalence rates increased among American 
Indian and Alaska Native people by almost 50% in the 1990s (Acton et al., 2002).  The 
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disparity in diabetes prevalence indicates the need for improved methods of chronic care 
among American Indian and Alaska Native people. 
Among American Indian and Alaska Native people, some groups have even 
higher incidences of diabetes.  The Pima Indians of Arizona have over a 50% rate of 
diabetes, which is the highest rate of diabetes among any group in the world (Shulz et al., 
2006).  American Indian and Alaska Native people are more than twice as likely to be 
diagnosed with diabetes as the general U.S. population, as well as three to four times 
more likely to have complications from their diabetes (IHS, 2007).  The rate of heart 
disease among Native Americans is now twice that of the general population (IHS, 2003), 
and is the leading cause of death among Native American Indians (IHS, 2013).  These 
rates point to the need for improvements in chronic disease care and prevention among 
American Indians and Alaska Native people.   
Factors contributing to these health disparities include limited health insurance 
(Medicaid, Medicare, or private), issues of quality of care, and a lack of access to 
appropriate health care facilities (Office of the General Council, 2004) and funding.  
Chronic underfunding has been a long standing issue in the Indian Health Service, the 
federal agency tasked with the care of Alaska Native and American Indian individuals.  
The Indian Health Service receives $4.1 billion, which amounts to expenditures per 
person that are well below other agencies such as Medicaid, Medicare, and the Veterans 
Administration (IHS, 2013; Sequest et al., 2010).  The Indian Health Service has limited 
resources compared to other agencies which has limited their ability to respond to chronic 
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care needs.  Other issues have also impacted the provision of adequate chronic care 
within the Indian Health Service. 
Another of these recurring issues for the provision of adequate care for chronic 
disease conditions is understaffing and provider turnover.  High turnover leads to gaps in 
coverage and disrupts continuity of care.  In exit interviews, IHS providers reported that 
poor quality of housing, remote location of assignments, low pay compared to private 
sector, and overwhelming patient loads lead were factors leading to their resignation 
(Kim, 2000; Office of the General Counsel, 2004).  Many issues impacted the ability of 
the IHS to provide adequate chronic care.  Discussions about this issue within the IHS 
and in consultation with tribal partners and other entities lead to the development of a 
patient care collaborative. 
Indian Health Service Patient Care Collaborative 
In an attempt to address patient care issues and systems issues, the Indian Health 
Service partnered with the Institute for Health Care Improvement in 2006 to develop the 
Improving Patient Care collaborative (IPC).  The goals of IPC are to (a) improve access 
to primary care, (b) provide primary care that is high quality, (c) provide care that is 
coordinated across the continuum of primary care, inpatient care, and care in the 
community, (d) promote changes guided by input from the American Indian and Alaska 
Naïve community and Tribal leaders, and (e) make changes in care that are measurable 
and real (IHS, 2012). 
6 
 
Collaborative Goals  
The purpose of the IHS Improving Patient Care Collaborative was to improve and 
change the IHS.  To accomplish this goal, the IHS plan was to develop high performing 
and innovative health care teams.  The goal was to aim for improved access to care and 
improved quality of care for American Indian and Alaska Native people.  Expected 
results include strengthened relationships between the health care providers and the 
various American Indian and Alaska Native communities, as well as improved health 
outcomes (IHS, 2012).   
The IHS identified 11 high leverage changes that were to be accomplished by 
collaborative.  These changes include (a) engaged leadership, (b) improved capacity, (c) 
developing mechanisms for communication, (d) mobilizing resources, (e) ensure 
community participation in IPC processes, (f) assisting patients with self-care, (g) 
empanelment, (h) multidisciplinary care teams, (i) enhanced access to care, (j) evidence-
based practice, and (k) improved clinical information systems (IHS, 2011).  Leadership 
was to be engaged in the process at multiple levels (e.g., team leaders, midlevel managers 
and top leadership).  Leadership not only received training on improvement processes, 
but also on how to motivate teams and empower them to make changes.  
 Improvement capacity and capability was to be built into the entire system and 
not just the clinical sites; Methods of listening to and communicating transparently with 
staff and the community were in development.  The organizations were to mobilize, 
facilitate care coordination, and partner with community resources. 
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The Improving Patient Care (IPC) 3 was the third cycle of the program and had 
89 participant organizations.   UWC participated in IPC 3, lasting 18 months, is a part of 
the Quality and Innovation Learning Network (QILN), a continuation of the care 
improvement journey.  The IPC was in its fourth cycle of the program within the IHS.  
The 32 organizations across the United States were participants in IPC4, and included 
hospitals and clinics operated by the federal government via the IHS, urban Indian 
Centers and hospitals, and clinics managed by American Indian and Alaska Native tribes.  
IHS was anticipating 100% participation in IPC by all IHS facilities and organizations, 
whether federal, urban, or tribal by 2015 (IHS, 2013).  The goal of IHS was to transform 
the way service is delivered to Alaska Native and American Indians (Roubideaux, 2011). 
Statement of the Problem 
The rate of diabetes and other chronic illness among Alaska’s Native people has 
steadily increased over the last 20 years.  Past programs and the delivery of care have not 
been successful in changing the outcomes for American Indian and Native Alaskan 
people with chronic diseases.  Researchers have described the outcomes of participation 
by large practices or organizations (Asch, Baker, & Keesay, 2005: Chin et al., 2007; 
Daniel et al., 2004; Grossman et al., 2008).  However, in the search for information about 
small health collaboratives, few studies appeared.  Little is known about quality 
improvements in the IHS and the results of participation in health care collaboratives and 
networks, particularly their impact on rural clinics.   
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Purpose 
The purpose of this study was to evaluate the process and outcomes of 
participation in the IHS IPC collaborative for a small tribal health organization, the 
Ukudigatunal Wellness Center (UWC).  In this study, I described the implementation of 
IPC at the UWC and evaluated the effect of participation in the IHS/IPC on the 
organization’s performance and selected patient outcomes. 
Nature of the Study 
The study was quantitative in nature and used evaluation methodology to 
determine the impact of participation in the IHS IPC collaborative.  The model used as a 
framework for the study was the chronic care model as modified by the IHS for the 
collaborative and the model for improvement.  Archived data collected during the 
collaborative was used to develop statistical run charts as described by Carey and Lloyd 
(2001) and Langley et al. (2009).  Run charts are included to assist in the evaluation of 
various IPC process and outcome measures and process measures for screening rates for 
both preventive and chronic care.  Some outcome measures, such as percent of patients 
with good glucose control or good blood pressure control, were also a part of the database 
for evaluation.  I used archived data collected during the collaborative.  The population 
under study was a small (fewer than 10 employees) Alaska Native nonprofit clinic 
located 800 air miles the parent company and closest hospital in the Aleutian Islands. 
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The Research Questions 
The principal research question for the study was the following: Did participation 
in the IPC improve the delivery of care and outcomes at the clinic?  The associated 
questions included the following: 
1. What criteria did the organization use to measure the success of the 
implementation? 
2. What was the effect of this implementation on the organization’s 
performance? 
Conceptual Framework for the Study 
The conceptual framework included the Wagner (2001 chronic care model and 
the Deming (1986) model for improvement.  These models formed the core framework to 
evaluate the IHS IPC collaborative, as developed by the Institute for Health Care 
Improvement.  The basis for all collaborative learning sessions, team activities, and 
changes was the chronic care model and the model for improvement.   
The Chronic Care Model 
The chronic care model (CCM) is an evidence-based mode developed to improve 
the care of chronic disease (Wagner et al., 2001; Wagner, Austin, & Von Korff, 1996).  
Wagner, in collaboration with the Improving Chronic Illness Care Program of the 
MacColl Institute for Healthcare Innovation, developed the model.  The CCM (see Figure 
1) incorporates factors conducive to more positive interactions between health care 
providers and those with chronic illness.   
10 
 
 
Figure 1. The chronic care model 
(Wagner, 1998) Republished by permission see Appendix A.                                                                                                                                                                                                                             
 
In the chronic care model, community resources and policies join with health 
system resources.  The redesign of the health care system ensures that individuals have 
the skills to self-manage their chronic illness.  An improved health care system design 
would impart to providers the information they need to make clinical decisions in regard 
to chronic care.  In theory, interactions between the provider and the patient in this 
improved system will lead to improved patient outcomes and improved provider and 
patient satisfaction (Wagner, 1998). 
 The IHS IPC program has further adapted the chronic care model to reflect care 
within Alaska Native and American Indian Communities.  See Figure 2. 
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Figure 2: IPC care model 
(Indian Health Service, no date). 
 
The Model for Improvement 
The MFI is another key conceptual dimension used in the IHS IPC program.    
The bases of this model were three key questions. 
1. What are we trying to accomplish?  
2. How will we know that a change is an improvement?  
3. What changes can we make that will result in improvement?  (Langley et 
al., 2009). 
These key questions were in turn connected to the Plan-Do-Study-Act cycle (Figure 3). 
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Figure 3: Model for improvement (Langley et al., 2009) 
  
According to Langley et al. (2009), the model did not replace other change 
models, but instead accelerated improvement through the use of small plan, do, study, act 
(PDSA) cycles.  The model was not a rigid one and could easily be useful in a variety of 
settings from large organizations to small organizations.  The purpose of the model was 
to test changes on a small scale before being applied system wide.  When doing testing 
on a small scale, multiple tests ran easily. 
Definitions 
Action plan: Work plans prepared by teams to guide tests for change, 
implementation, and spread (IHS, 2014). 
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Chronic disease: A condition that is ongoing (a year or more), requires continued 
medical care, and/or limits in some way activities of daily living (Ward, Shiller, 
Goodman, 2014).   
 Clinical Information System (CIS): An integrated, comprehensive, patient-
centered information system like the Patient and Registration Management System 
(RPMS) (IHS, 2014). 
 Cycle time: The amount of time that a patient spends at a clinic visit.  The cycle 
time is used to identify areas of backlog that can be improved (HIS, 2014). 
 Micro system: A smaller portion of the entire organization like one clinic or one 
provider in a clinic (IHS, 2014).   
 For a more complete list of definitions please see Appendix B. 
Assumptions 
 The chronic care model was an appropriate foundation for the study.   
 Procedure and process change would improve patient outcomes.   
 Patients would provide responses, according to their personal experiences. 
 The RPMS was consistent in its data collection process. 
Scope 
The population in this study attended a small Alaska Native clinic.  The micro 
system (subset for the IPC process) was the medical portion of the clinic.  The 
organization support staff and parent company, located in Anchorage, was not included in 
the IPC program or the evaluation.  Findings in this study would be applicable to other 
small clinics and other tribal health facilities. 
14 
 
Limitations 
 With the size of the organization, the outcomes may not be transferable to 
larger organizations. 
 The IPC collaborative is IHS specific.  The results may not be applicable 
to non-American Indian or Alaska Native clinic. 
 The behavioral health component of the clinic was not included in the 
evaluation for the IPC.   
Significance 
This study provided information on the impact of participation in the IHS IPC 
collaborative for a small Alaska Native Tribal Health Clinic.  As such, it may provide 
guidelines for other small clinics that are attempting to improve their patient care for 
chronic disease.  Results may have potential social implications for individuals with 
chronic disease who may have less disability and live longer with improvements in 
patient care. 
This study was unique because I addressed an area that few scholars have 
examined.  Quality improvement was a relatively new field (Sifrim, Barker, & Mate, 
2012).  Since 2009, tribal organizations, IHS organizations, and Urban Indian Health sites 
have been participating in IPC, yet little research has emerged about the process or 
impact on their participation.  Also missing from the literature are studies about quality 
improvement in small organizations with few resources.  The results of this research 
increased knowledge about the impact of participation on a small, nonprofit, tribal health 
organization. 
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Summary 
Chronic illness places significant strain on the health system in the United States 
and even more so for providing care to Alaska Natives and American Indians.  The IHS 
has adopted chronic care collaboratives as a means of improving care for those 
beneficiaries receiving care at IHS clinics, Urban Indian Health Centers, or Tribal health 
facilities.  These collaboratives use the model for improvement and the chronic care 
model as the basis for improving care.   
In the next chapter, literature relevant to the problem will be reviewed to provide 
a basis for understanding the problem, and to understand concepts and issues relevant to 
chronic care collaboratives, the chronic care model, and the model for improvement.  
Chapter 2 provides a review of the literature, covering a variety of studies in improving 
chronic disease management.  Additionally, a review of studies in which collaboratives 
improve chronic care follows.  Finally, studies on the evaluation of chronic care 
improvement as a research methodology are explored.   
Chapter 3 includes the purpose of the study with a description of the methodology 
for the study.  Also presented is a description of what patient care outcomes changed as a 
result of participation in the IPC.  Concluding this chapter is a description of how I 
evaluated whether the organization was able to meet their goals set forth at the beginning 
of their participation in IHS/IPC.   
In Chapter 4, I present the results from the data collected on the IPC measures: the 
collaborative results for both process and outcome measures.  The process measures 
include such items as screening for domestic violence and other preventive care and 
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screenings.  Outcome measures include control of blood pressure, control of lipids, and 
control of HgbA1c.   
Chapter 5 is a brief overview of the study, a summary, and interpretation of the 
findings and conclusions.  The chapter also includes a discussion of the implications for 
social change and recommendations.  The chapter ends with my reflections on the study. 
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Chapter 2: Literature Review 
Introduction 
The purpose of this study was to evaluate the process and outcomes of 
participation in the IHS IPC collaborative for a small tribal health organization in Alaska.   
This chapter includes a review of the literature pertinent to improving health care.  The 
topics covered in this chapter include the following: chronic disease care and need for 
improvement, collaborative studies and chronic disease management, collaborative 
studies to improve systems, problems with collaborative studies, studies using the chronic 
care model, and evaluation as a research methodology.  
I identified studies through EBSCO Host through the Walden University library, 
from the National Library of Medicine (PubMed), and Google Scholar.  I also obtained 
print articles from the University of Alaska Anchorage Health Sciences Library.  Key 
words searched included the following: chronic care, chronic care and improvement, 
quality care, health care and improvement, health care and collaboratives, chronic 
disease care, chronic disease care and improvement, chronic care model, model for 
improvement, American Indian and Alaska Native health care, and evaluation research.  
I obtained articles going back to the 1980s to 1990s to get original articles relating to 
chronic care and the model for improvement.  My major focus on collaborative studies 
were from the last 10 years.     
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Types of Studies 
Chronic Disease Management 
Chronic health conditions are challenges to the health care system.  Many 
investigators (Bodenheimer, 2003; Burwick, Nolan, & Whittington, 2008; Duckers, 
Wagner, & Groenewegen, 2008; Hroscikoski et al., 2006; McGlynn et al., 2003) have 
found that health care provided to persons experiencing chronic disease is inadequate.  
Seventy-six percent of adults in the United States have received screening for 
hypercholesterolemia (Centers for Disease Control, 2012).  However, more than 80% 
with hypercholesterolemia also have levels above those recommended (Ford, Li, Pearson, 
Zhao, & Mokdad, 2010).  
Eighty percent of adults with asthma have uncontrolled disease (Calhoun et al., 
2012) and 50% of people with high blood pressure have readings that are above ranges 
considered to be controlled (Egan, Zhao, & Axon, 2010).  Another 43% of individuals 
with diabetes do not have controlled blood sugars (Cheung et al., 2009).  Additionally, 
even though recommendations for best practices exist, care for individuals with chronic 
disease varies widely among providers (Bodenheimer, Chen, & Bennette, 2009; Kilo, 
1998; United States Department of Health and Human Services (USDHHS), 2009).  
Expert recommendations and best practices were available for providers in the provision 
of care to their patients with chronic conditions.   Collaboratives were one method 
proposed to help providers improve care provided for chronic conditions. 
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Collaborative Studies Research 
Studies on improving health care quality were sparse until the 1950s (Stiles & 
Mick, 1994).  At that time the Joint Commission on Accreditation of Hospitals (JCAH), 
now the Joint Commission, formed and through its various work on accreditation of 
hospitals and clinics increased the quality of health care research (Goran, Roberts, & 
Rodak, 1976).  During this time, Donabedian conceptualized three dimensions of quality: 
structure, process, and outcome as the framework for improving health care (Williams & 
Torrens, 2002).   
By the mid-1980s, an increased interest in quality of care was a driver for 
concerns over escalating health care costs (Stiles & Mick, 1994).  In response to this 
concern, health care organizations looked to alternative models found in manufacturing 
and other non-health industries for new ways to improve health care delivery (Berwick, 
1989; Chassin, 1997; Shah & Layman, 2005).  Initial quality improvement focused on 
administrative areas, such as record keeping, scheduling, and billing (Ferlie & Shortell, 
2001).  Later quality improvement focused on improvement of the entire health care 
system.  It was during this time that studies on collaboratives began to appear. 
Collaborative Care Management 
The Institute of Medicine (IOM) published two landmark reports regarding health 
care delivery.  The first report from IOM (2000) focused on the number of patients killed 
or injured each year as a result of medical error.  This report was an impetus for providers 
to begin addressing quality within their organizations.  In a follow-up report, IOM (2001) 
reviewed causes of the gap in quality health care.  In this second report, the IOM (2001) 
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acknowledged that (a) health systems were complex and (b) these systems needed 
redesign if they were to meet the needs of patients in the health care system. 
The Institute for Health Care Improvement (IHI) was another entity whose main 
activity is to improve health care systems and health care quality.  At its inception, the 
IHI focused on providing courses on quality improvement.  However, scholars who 
examined studies associated with HIS activities failed to demonstrate evidence of any 
significant change in care or quality (Kilo, 1998).  In 1999, the IHI made a fundamental 
change in their methods for bringing about quality care improvement by instituting a 
collaborative model.   
The purpose of this model was to support changes at the organizational level and 
bring about improvement in chronic health care.  Instead of taking place in a onetime 
event, subsequent collaboratives took place over an extended period of time and involved 
face-to-face learning sessions followed by periodic phone conferences (IHI, 2012).  
Organizations participating in a collaborative agree on the improvement goals and 
monitored their ongoing progress through gathering data on specific measures.  Teams 
submitted projects for improvement and use small change cycles to move their clinical 
site toward improvement (IHI, 2012).  Quality improvement collaboratives were among 
the most widely used models in health systems around the United States (Grossman et al., 
2008).    
Research on Health Improvement Collaboratives 
The results from collaboratives were primarily positive.  Collaboratives for 
improving the care of depression had a positive effect on patient outcomes (Gilbody, 
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Bower, Fletcher, Richards, & Sutton, 2006).  Multiple care collaboratives to address 
diabetes self-management and improve blood sugars showed positive results (Asch, 
Mangione, Broder, Rosen, & Keeler, 2007; Fleming et al., 2001).  In contrast to these 
positive results, some researchers found progress in care, but little improvement in 
disease outcomes (Landon et al., 2007).  Although evidence supporting improvements in 
patient outcomes with clinic participation in a patient care collaborative is contradictory, 
those studies finding positive outcomes were more common than those with no 
improvement.  Further information about studies for specific chronic conditions will be 
covered later in this chapter.  
Collaboratives to improve care for chronic diseases came into existence in the late 
1980s (Kilo, 1998).  A variety of clinics, hospitals, or other interested health 
organizations came together for a period of time to improve some aspects of patient care.  
The participants engaged in a series of meetings (e.g., virtual or face-to-face) to gain 
knowledge about best practices, how to improve quality, and how to make changes in 
their own organizations.  The specific purpose of a collaborative could vary.  Some strove 
to improve patient outcomes, such as decrease average blood sugar (Rosenqvist, Carlson, 
& Luft, 1988) or decrease drug errors (Leape et al., 2000).  Others sought to decrease 
hospital costs and lengths of patient hospital stays (Reid et al., 2010) or provide support 
for health care providers (Grossman et al., 2008).  The Institute for Health Care 
Improvement was one example of an organization responsible for organizing over 1,000 
different clinics, hospitals, and other health entities into patient care collaboratives.   
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Quality improvement collaboratives used multiple approaches to improve care.  
Some collaboratives focused on specific chronic health care problems, while others 
focused on improving systems.  The following is an examination of chronic condition-
specific studies and those involving systems change.  The results of collaboratives in 
terms of improving patient care have been mixed.  Koffman, Granade, and Anwun (2008) 
reported that belonging to a chronic disease collaborative leads to improved outcomes for 
patients with cardiovascular disease.  Daniel et al. (2004) reported that a Washington 
state diabetes collaborative in 1998-99 and in 2000-2001 showed improvement in process 
measures and less in outcomes measures.  The size of the participating organization 
participating in the diabetes collaborative varied from large to single office practices.   
Similar results appeared in a North Carolina diabetes disparity collaborative in 2000-
2001.   
Improvements in several process measures included increased self-management 
education for patients, increased use of a diabetes registry, and improved decision support 
for providers.  The only reported outcome measure to show improvement was HbgA1c 
levels (Wang et al., 2004).  Chin et al. (2004) reported similar results in a study of 19 
community health centers (CHCs) involved in a diabetes collaborative.  Participating 
CHCs showed significant improvements in care processes, but not intermediate 
outcomes.  Participants in both of these collaboratives self-reported their data and their 
own evaluation of outcomes.  No outside observer or validation of the data or processes 
existed.   
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 Asthma care process showed improvement with participation in patient care 
collaborative (Schonlau et al., 2005).  Patients in the intervention group who attended 
educational session, set goals, monitored peak flow rates, and used asthma medications 
correctly showed a slight increase in control.  However, the change was not significant.  
Homer et al. (2005) reported no improvement in asthma care in a randomized trial of 
collaborative participation.  Theorized was that negative outcome might be related to a 
short follow-up period and also a low participation rate.  Asthma care was one area of 
chronic care that may or may not be helped by clinic participation in a collaborative.  
Time also appeared to be a factor.  Changing entire patient care systems took time, so 
following a clinic for a longer period of time might be a factor in positive outcomes.     
A collaborative for depression care involving 18 different clinics in a large 600 
provider multispecialty health group showed only small process improvement.  The 
degree of improvement varied widely among the groups and seemed more connected to 
personalities on teams rather than actual systems change.   The authors concluded that 
changes were only the first step toward quality improvement and more time was needed 
to fully see the concept of implementation of the CCM fully realized (Hroscikoski et al., 
2006).  In contrast, Dwight-Johnson, Eli, and Lee (2005) found that when a clinic staff 
was involved in depression collaborative, patients in an intervention group had improved 
emotional well-being.  The changes were thought to contribute to the positive outcome, 
specifically, case management, physician feedback, self-management support, and 
proactive care.   
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Authors of other studies have not differentiated between chronic diseases and 
instead look to improve the system providing care across the spectrum of chronic 
diseases.   Systems changes made by organizations seeking to improve diabetes care 
included: (a) providing case management for difficult cases, (b) forming collaborative 
teams within the clinic, group visits, (c) developing systems to identify those with 
diabetes, (d) regular registry reports, (e) system prompts for diabetes testing, and (f) using 
a population approach (Spere-Hillen et al., 2000).   
Problems with Collaborative Studies 
 One criticism of outcomes of collaborative was the difficulty in identifying which 
of the changes in a collaborative are responsible for improved outcomes (Spere-Hillen et. 
al., 2000).  The conclusion that one may make from all of these studies was that 
collaboratives addressing the entire system had the greatest impact on patient outcomes.  
All the components of the IHI collaboratives enhanced primary care across the spectrum 
of chronic disease.  The studies above revealed positive results in large organizations, 
small medical practices and both rural and urban settings.  However, the literature lacked 
studies in several areas.  This study filled in gaps in the literature both in term of 
remoteness of this particular setting, limited infrastructure capacity and one that took 
place in an Alaskan Native setting. 
Chronic Care Model 
The aim of the CCM was to modify health care delivery systems in ways that 
made the patient the center of the visit.  In an organization utilizing the CCM, visits 
should be proactive, planned and population-based (Coleman et al., 2009).  The CCM 
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had interventions within six core areas to improve care and patient outcomes.  These 
areas of change included: (a) redesign the system of health care delivery, (b) provider 
decision support, (c) information systems, (d) community connections, (e) patient self-
management support, and (f) health system organization (Glasgow et al., 2002).   
The purpose of the majority of reviewed studies was to examine ways of 
improving chronic disease patient care using the chronic care model (CCM).   These 
studies vary widely in the degree to which they incorporated the CCM and generally 
organized  around one or more components of the chronic care model as listed above 
(Coleman, Austin, Brach, & Wagner, 2009).  The majority of studies using the chronic 
care model took place within collaboratives (Coleman, et al., 2009).  The chronic care 
model had also been used widely in studies not associated with a patient care 
collaborative. 
In contrast to the studies mentioned above, other studies with programs 
incorporating components of the chronic care model outside of participation in a 
collaborative also made improvements (Minkman, Ahaus, & Huijskan, 2007; Ouwens, 
Wollersheim, Hermens, Hulscher, & Grohs, 2005; Tsai, Morton, Mangione, & Keeler, 
2005).  Small, private practice clinics reported that their offices were able to make 
process improvement and additionally some outcome improvement in implementing the 
CCM.  Although they were not able to achieve their original organizational target goals, 
improvements occurred in percent of patients with controlled blood pressure, A1C levels 
and LDL cholesterol levels.  An additional bonus of incorporating the CCM was 
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improved provider and patient satisfaction.  After three years, patient outcome 
improvements continued to be made (Mohler & Mohler, 2005).   
Although the conceptual framework for the CCM was well developed, no specific 
steps or methods were available to guide clinical practices interested in its 
implementation (Hroscikoski et al, 2006).  Groups must figure out how the model fit in 
their particular system.  Participating in a collaborative with CCM was one method to 
enable organizations to evaluate their own system and introduce the organization to the 
change process. 
Evaluation as a Research Method 
The tradition of evaluation as a discipline was fairly young (Pawson & Tilley, 
2011).  In the 1960s social program evaluations in the U.S. began as the cost of social 
welfare rapidly expanded (Bell, 1983).  These experiments created interest in the 
financial, professional and academic communities, and evaluation as a method spread 
rapidly (Sadish, Cook, & Eviton, 1991).  This movement continued with the development 
of evaluation societies being founded in the UK, Europe and Australia between 1994 and 
1995 (Pawson & Tilley, 2011).   
 According to Pawson and Tilley (2011), the four main perspectives for evaluation 
research included: experimental, pragmatic, naturalistic and pluralist approaches. The 
basis of early evaluation research was experimentation logic with one group receiving an 
intervention or treatment and the other none.  The theory of causation was the basis for 
this type of study.  If the control and test groups were similar before the beginning of the 
program, then the assumption was that the program was the cause of the change.  By 
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inferring causation, the researcher attempted to control for any other potential cause 
agent.     
One of the earliest studies of social change and experimental research was the 
Sesame Street study (Bogatz & Ball, 1971).  The underlying principle of the study was 
the idea that children’s brains changed rapidly between the ages of two to five and early 
education gave children a jump start.  The outcome of this research was a series of 
educational television programs (Pawson & Tilley, 2011).  Other early evaluation studies 
were on prison reform (Martinson, 1974; Ross & Gendreau, 1980).   
One issue being discussed during this period was the capacity of the experimental 
approach to develop enough evidence to support public policy.  Eventually, researchers 
concluded that if enough experimental studies were completed, patterns would develop 
and predictions become possible (Pawson & Tilley, 2011).   
 A second perspective of evaluation research was pragmatism.    In this view the 
researcher investigated utility, feasibility, accuracy and propriety (Pawson & Tilley, 
2011).  Here researchers used a variety of tools to collect information through sampling, 
interviews, questionnaires, and analysis of data (Patton, 1980).   The purpose was to 
determine whether a program was feasible in terms of finance, politics, and achievability.    
 In the 1970s phenomenology and naturalism became popular. In this type of 
study, program evaluation could not be treated merely as a set of independent/dependent 
variables, but rather as understanding the complex processes that involve human 
interaction.  The concepts of phenomenology and naturalism lead to some important 
developments in research evaluation.  One of the first was the concept of evaluation as 
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processes rather than examining outcomes.  These studies involved the inclusion of 
stakeholders in program development and negotiations over program changes.  The 
stakeholders were the primary voice, not the researcher (Guba & Lincoln, 1983).   
The main concern about the naturalist approach was that its context would affect 
the actions and thoughts of stakeholders.  The outcomes would most likely vary from the 
past and be different in the future, as well as results from the same study done in different 
groups (Pawson & Tilley, 2011).    
 Pluralism incorporated methods from several types of studies including 
experimentation, policy making, and involving stake holder views (Rossi & Freeman, 
1985).    This type of evaluation approach had both breadth and depth and as such 
required more resources than other methods.  In this approach, theory drove evaluation.  
Theory driven evaluation anticipated variation in the delivery of a particular program and 
built alternative comparisons into the design (Pawson & Tilley, 2011), an idea first 
introduced by Chen and Rossi (1981).   
The study of improvement had traditionally involved three types of data: 
classification, count and continuous.  Continuous data were often called variables data.  
For classification data, descriptors were one of two categories.  Examples of 
classification data included positive/negative, good/bad.  Count data included 
objectionable attributes (e.g., number of medication errors) or the amount of a particular 
unit (e.g., the number of patient visits to a clinic).  These counts were continuous 
variables because the intent was to follow the progression of either improvement or lack 
of improvement (Provost & Murray, 2011).   
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Studies Using Evaluation as Methodology 
 Evaluation research in medical care was generally multifaceted.   Depending on 
the structure and purpose of the particular program, many different approaches were 
available. One popular method in evaluation research was surveys of key stakeholders 
including administrators, mid-level managers, community members, primary care 
providers, program recipients, or other individuals involved in the development, 
provision or analysis of a particular program.   
In their evaluation of tobacco cessation activities in 60 New York City low 
income clinics, Hung and Shelly (2009) developed surveys with the six components of 
the chronic care model.  For example, in developing questions to address delivery system 
design, they asked binary questions, 1(for yes) and 2 (for no), as to whether the clinic 
conducted group visits, offered activities for smokers contemplating quitting, a dedicated 
tobacco cessation program coordinator, and whether the clinic dedicated tobacco 
treatment specialists to provide cessation counseling.  Each of the six chronic care model 
components likewise had survey questions.  Some of the questions involved a scale, such 
as 0 (for never) to 1 (always), but no open ended survey questions.  Use of clinical 
information systems, such as electronic health record reminders and registries, was the 
strongest correlate of tobacco cessation after adjusting for all other CCM elements.   
Damin et al. (2008) used surveys differently.  They administered purposefully-
directed surveys of 12 health centers in Australia providing care to indigenous people.  
These surveys were both mailed and on-site face-to-face group interviews.  The mail out 
survey was for information on clinic resources and financing, and personnel relating to 
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chronic care.  The taped, in-person interviews involved staff asking to comment on 
successes and difficulties in provision of chronic illness care.   The mailed survey 
questions revolved around all 6 components of the CCM.  The face-to-face survey 
involved collation using a SWOT (strengths, weaknesses, opportunities and threats) 
format.  
Other evaluation studies had outcome and/or process measures to determine the 
effectiveness of the intervention or program.  In a study evaluating the effectiveness of 
team care working with individuals with depression (Johnson et al., 2012) used outcome 
and process measures.  The results of provider documented depression scales and scaled 
marginal model were the results as their outcome measures.  Process measures included 
the number of visits with providers, use of medications and specialty care referrals.  
Surveys were instruments used for all program participants as validation of provider 
reported outcomes. 
Another evaluation of asthma care collaboratives compared 6 different clinics and 
found that improved process of care measures linked to better self-management.  Patients 
also reported increased satisfaction with their care and communication with their 
provider.  However, the collaborative time (12 months) was too short to detect any long 
term improvement in health for those individuals with asthma (Schonlau et al., 2005).   
One potential weakness of self-reported data was that activities, such as health 
behavior modification counseling, could be overestimated (Thorndike, Rigotti, Stafford, 
& Singer, 1998).  In contrast, Hung and Shelley (2009) found that patient reports of 
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behavior modification counseling did not significantly differ from what the provider 
reported.    
Summary 
Patient care collaboratives come in many shapes and sizes, and overall research 
provided evidence that they improved patient care.  The basis for the majority of patient 
care collaboratives was either the model for improvement and/or the chronic care model.  
The chronic care model was particularly complex with researchers having difficulty 
trying to differentiate which part of the model was responsible for improving patient care.   
Evaluation as a research methodology was relatively new with many different 
ways in which evaluation was useful in research.  For this study both process and 
outcome were measures of the evaluation of the collaborative.  This type of research was 
appropriate to the study being undertaken. 
Chapter 3 is a description of the study methodology and rationale for the proposed 
research.  The chapter includes an in depth description of the research setting and the IPC 
program.  In addition, research design, data collection procedures, data analysis methods 
and the role of the researcher conclude the chapter.   
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Chapter 3: Research Method 
Introduction 
This chapter is a presentation of the methodology and rationale for the research 
and includes the research setting and programs to be was evaluated, research design, data 
collection procedures, data analysis, the role of the researcher, and the ethical issues 
associated with this study.  The integrated central concepts of evaluation were a part of 
the research design, and the evaluation development of the research method was in 
relation to the IHS/IPC collaborative.    The research focus was on the change (happened 
and planned) that occurred during the course of participation in the IHS/IPC 
collaborative.   
The purpose of this evaluation research was to evaluate the effect of participation 
in the IHS/IPC on the organization’s performance and selected patient outcomes.  The 
data collection involved descriptions of what patient care changes took place as a result 
of participation in the IPC.  Changes in patient outcomes (e.g., percent of patients 
HgbA1C in control, percent of patients with BP in control) were points of evaluation, as 
well as process changes screening for various health indicators such as screening for 
Body Mass Index (BMI), tobacco use, and cancer screening.  Additionally, this 
examination included whether the organization met its goals set forth at the beginning of 
their participation in IHS/IPC.  The time frame was the period of implementation and 
participation in IPC/QILN from December 2011 to June 2013.   For a description of the 
IPC process, see Appendix C. 
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Research Approach 
The purpose of this study was to determine the effectiveness of the 
implementation of the IPC goals by analyzing data from its implementation of IHS/IPC at 
UWC over a 15-month period.  The research questions were the following: (a) Did 
participation in the IPC improve care at the clinic and (b) What was the impact of the IPC 
collaborative on identified process and outcome goals?  The data gathered involved 
indicators related to patient care improvement.  Data collected were from computer 
software programs tied to the clinic electronic health record including iCare (a 
population-based patient management system) and the IHS RPMS. 
Research Setting and Program 
Description of the Clinic 
 The research setting was a small, tribally run clinic, the Ukudigatunal (a 
pseudonym –an Aleut word meaning good health) UWC, located on a remote island in 
the Aleutian Islands of Alaska, 800 air miles from the nearest hospital.  The research 
setting was limited only to the medical clinic.  The concept of IPC was to start small in a 
microsystem and then broaden it.  The medical clinic was the microsystem where the 
initial IPC activities took place.   
The clinic was in a leased building situated centrally between two population 
centers located on separate islands.  A bridge joined the two islands.  The clinic was one 
of four clinics on the island.  In addition to UWC, two chiropractor clinics and a larger 
clinic were part of the Health and Resource Administration (HRSA) clinic or Community 
Health Center (CHC).  UWC consists of two exam rooms, a small dispensary, a small 
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lab, a dental operatory, an x-ray unit, and several offices.  The behavioral health offices 
and social worker offices are located off site at another building due to lack of space in 
the present facility 
Available Clinical Services 
UWC is a primary care clinic.  The clinical providers (Family Nurse Practitioner, 
Physician’s Assistant and Community Health Aide manage care for patients across the 
life span.  Services provided include preventive care, such as well child checks, 
immunizations, prenatal care, women’s annual exams, men’s health, sports physicals, and 
teen health.  In addition, care was available for most acute illnesses and minor 
emergencies.  Chronic care for most chronic conditions was also available as was end of 
life care.  The clinic staff also conducted home visits for elders or others who are unable 
to make it to the clinic for their visits.  Staff also were involved in community outreach, 
such as diabetes prevention fun runs, health fairs, weight loss competitions, and public 
services announcements on a variety of topics. 
The clinic staff referred all significant trauma or extremely ill patients to the CHC 
with their staff of two physicians, three physicians’ assistants/nurse practitioners, three 
registered nurses, and six medical assistants.  Medical assistants double as lab techs and 
radiology techs.  The community health center had a three bay emergency room with a 
trauma room, a moderate complexity lab, and full x-ray services.   
Prenatal patients went off island at 37 weeks to await delivery in Anchorage.  
UWC referred their patients for delivery at the Alaska Native Medical Center.  The 
hospital provided housing either at patient quarters in the hospital or at a local hotel until 
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delivery. The clinic had a patient population base of 350 individuals (IHS, 2013).  About 
30% of the clinic population was under the age of 18 and 17% are over the age of 60.  
The number of patients seen each month ranged from 90-120.  The busiest times of the 
year was during the various fishing seasons (e.g., cod, halibut, salmon, and king crab) in 
the area.  In addition to local qualified residents (e.g., Alaska Native or American Indian 
who were permanent residents), the UWC clinic had Alaskan Native or American Indian 
patients who traveled to the island to work in the local fish processors.   
The island’s population was approximately 4,500 people living on the island year 
round.  However, during the Alaska pollock (a species of cod) and crab fishery seasons, 
the population could increase to 9,000.  Most seasonal workers came from the contiguous 
United States or overseas.  The clinic staff saw about ten new American Indian/Alaska 
Native patients coming to the island for the fishery each year.  The active patient 
population for the clinic was about 350 individuals.  Hours of operation were 8:00 am to 
4:30 pm Monday through Friday.  The providers rotated taking call for after hours and 
weekend emergencies.  The provider on call carried a cell phone in case of an emergency.  
For more information on the history of the UWC see Appendix F.  For more information 
on the clinic personnel and clinic setting see Appendix G.  
Research Methodology 
 For this study, a summative evaluation method was the research design.  The 
primary focus and unit of analysis was the medical component of the UWC.  The primary 
overarching research question to be answered was the following: Did participation in the 
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IPC improve care at the clinic?  A second research question was the following: What was 
the impact of the IPC collaborative on identified process and outcome goals?   
 The methodology involved analyzing data collected during the collaborative on 
clinical process and patient outcome measures.  Process measures included screenings for 
general health risks, such as obesity, tobacco use, domestic violence/intimate partner 
violence, depression, elevated blood pressure, cervical cancer screening, screening for 
breast cancer, and screening for colorectal cancer.  The comprehensive diabetes care 
measure required that an individual receive a screening foot exam, blood pressure, 
nephropathy screen (urine for microalbumin) retinal exam, measurement of lipids, and 
HgbA1c within the last year.  A final process measure was tobacco users who received a 
cessation intervention (See Table 1).  These data elements were useful in answering both 
research questions as to the improvement of patient care and impact identified process 
goals.   
Patient outcome measures included in the study were blood pressure in control for 
individuals with hypertension and lipids in control for those individuals with elevated 
lipids and HgbA1c in control for individuals with diabetes (See Table 1).  Whether or not 
the clinic reached the goals established at the beginning of the collaborative answered the 
research question: Did participation in the IPC improve care at the clinic?  What was the 
impact on identified outcome goals? 
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Table 1 
 
Process and Outcome Measures with Associated Goals 
 
Patient Care Process 
Measures 
Measure Goal 
Preventive Screenings 
 
 
 
 
BMI 
Tobacco Screening, 
DV/IPC Screening Depression 
Screening 
Blood Pressure Screening  
Tobacco use screening 
Tobacco cessation provided 
Colorectal cancer screening, 
Cervical cancer screening, Breast 
cancer screening 
Foot exam 
HgbA1c measured 
Retinal eye exam 
80% 
80% 
 
80% 
80% 
80% 
70% 
70% 
70% 
70% 
70% 
70% 
70% 
Patient Outcome Measures   
Control of blood Pressure, 
Lipids & A1c 
Control of blood pressure 
Control of lipids 
Control of diabetes 
70% 
        70% 
        70% 
.    
To demonstrate the improvement or lack of improvement over time during the 
collaborative, run charts were the data source for each outcome and process measure.  A 
run chart or trend chart had data values shown as points connected by lines.  The purpose 
of a run chart was to show direction up or down and change of a specific measure over 
time.  The x axis was the time and the y axis, the measurement scale (Provost & Murray, 
2011).  The run chart was an appropriate method in quality improvement projects as a 
needed process to follow up over time to evaluate whether an improvement was due to 
chance or due to the implemented programs (Carey & Lloyd, 2001; Langley et al., 2009; 
Provost & Murray, 2011).  
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This research was an internal evaluation of the clinic organization.  One 
advantage to internal evaluation was that the researcher was familiar with the 
organizational operations and history.  One disadvantages to conducting an internal 
evaluation involved being too close to an organization, so that objectivity became more 
difficult. 
Role of the Researcher 
The researcher was part of the organization and worked in the clinic where the 
IPC Collaborative takes place.  Additionally, the researcher was familiar with the 
decision making style of the organization and could communicate results more 
frequently.  The role of the researcher was participant-observer.   
Due to the small size of staff in the clinic, it would have been impossible for the 
researcher to be only an observer.  The employer required all staff to participate in the 
IPC Collaborative.  The researcher was a co-worker to all the other members of the staff 
and  the supervisor to two of the staff, the medical assistant and the Community Health 
Aide.  The clinic administrator and staff in the Anchorage office directed IPC activities.  
Doing a study within one’s own work environment presented a particular challenge.    To 
maximize objectivity, the researcher reviewed the findings with the organization’s quality 
improvement program manager and the clinical applications coordinator.   
Study Unit 
The organization under study was the medical component of the Ukudigatunal 
Wellness Center (a pseudonym) excluding its behavioral health section.  The behavioral 
health clinic was off site, not a part of the electronic health record, and did not participate 
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in IPC activities. A total of seven employees staffed the medical clinic.  The patient 
population of the UWC was 350 active patients, including men, women and children of 
varying ages, and types of diseases.   
Instruments 
The Registration and Patient Management System (RPMS) and iCare tools were 
the processes for data collection to determine goal achievement.  These software 
programs were integral to the RPMS electronic health record (EHR) system and included 
de-identified data from the patient electronic health records. 
Data Collection Process 
Collection of data during the Improving Patient Care Collaborative was 
accomplished by using a variety of tools.  These tools included the RPMS data 
management system tool, such as (VGEN), Government Performance, and Reporting Act 
Reports (GPRA), Patient Care Component Query (QMAN), and iCare.  See Appendix D 
for the Data Collection sheet used during the collaborative.  For this study, the archived 
de-identified data, retrieved from the agency’s own archived records and submitted to the 
IPC program.    
Data Analysis Plan 
Data from 13 health related process measures and from three patient outcome 
measures were the sources for using Shewart type run charts.  The purpose of using the 
run charts was to follow the improvement or lack of improvement in these measures over 
the length of the collaborative (see Figure 4).  The patient-related process measures 
included:  
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 BMI measured:  This percent was for active patient (ages 2-84) screened for BMI 
in the last year.  An active patient was one who has been seen in the clinic at least 
two times in the last three years.  
 Tobacco screening: This measure was the percent of active patients (ages 5-84) 
screened for tobacco use in the last year.  
 DV/IPV screening: This percent of active patients (ages 16-84) who had 
screenings for domestic violence and intimate partner violence in the last year.  
 Depression screening: The number of active patients (ages 18-84) screened for 
depression in the last year.   
 Blood pressure screening: The number of active patients (ages 18-84) screened 
for blood pressure in the last year. 
 Tobacco cessation provided: The number of those active patients who used 
tobacco and received tobacco cessation counseling in the last year.  
 Colorectal cancer screening:  The number of active patients (ages 50-80) screened 
for colorectal cancer in the past year.  This screening could include fecal occult 
blood testing, sigmoidoscopy or colonoscopy.  
 Cervical cancer screening: The number of active women (ages 21-60) screened 
for cervical cancer in the last three years. 
 Breast cancer screening: The number of active women (ages 40-84) who had a 
mammogram in the last two years.   
 Diabetic foot exam: This measure was the number of active patients with diabetes 
who received a diabetic foot exam in the last year.   
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 Diabetic retinal eye exam: The number of active patients with diabetes who 
received a retinal eye exam in the last year.  This included an exam by an 
optometrist, ophthalmologist, or a retinal photo via Joselyn Vision Network 
(JVN) camera.   
The patient outcome measures included: (a) Control of blood pressure for all 
active patients with hypertension or diabetes who had a blood pressure under 140/90 in 
their last three visits.  (b) Control of lipids involved all active patients on lipid lowering 
medications with a LDL under 120 in the last year. (c) Control of diabetes included all 
active patients with diabetes with an HgbA1C under 7.0 in the last year.   
This type of data had traditionally been the type used in improvement evaluations 
(Provost & Murray, 2011).  Run charts provided descriptive statistics to document the 
percentage of patients in each health measure who received various preventive 
screenings.  By increasing screenings patients with elevated blood pressure and/or lipids 
could be identified.  Addressing these issues leads to improved health outcomes (Kern, 
Barron, Dhopshwarkar, Edwards, & Kaushai, 2011).  Information from these charts was a 
demonstration of the IPC impact on various processes and patient outcome goals.   
Data were trustworthy because either the goal was met or it was not.  
Triangulating took place between programs for the RPMS and iCare, which involved 
slightly different tools to gather the same data.  The agency Clinical Applications 
Coordinator (CAC) and the quality improvement program manager reviewed the data 
results.  Run charts were plots of data characteristics in chronological sequence and 
useful in revealing trends. 
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Figure 4: Example of a Run Chart 
 
  In the example above, the red line is the goal.  The green line was the percentage 
of patients over the age of five screened for tobacco use or exposure.  The dotted line was 
the median for all the data.  This example run chart showed steady progress in the 
number of individuals screened for tobacco use.      
 The run charts were part of the data analysis and provided the data to answer both 
research questions: (a) Did participation in the IPC improve care at the clinic, and (b) 
What was the impact of the Improving Patient Care (IPC) Collaborative on identified 
process and outcome goals?  By observing the run chart over time, the researcher 
interpreted whether a change occurred, no change noted, or an improvement.  This study 
provided data as signals of indicators that the anticipated for change was moving in the 
desired direction (i.e., the percent of patients with blood pressure under control was going 
up).  
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Issues and Procedures 
The parent agency Health Board approved the study.  The Walden University IRB 
approval number is 04-08-14-0064012.  Data eliminated patient identifiers and was 
anonymous.   Data stored on the local clinic server was accessible only by an agency 
providing a password changing every 90 days.  Data was accessible to the clinical 
applications coordinator (CAC), the quality improvement lead, and the researcher.   
The final results would be available and disseminated to the clinic staff, the 
agency leadership, and the Health Board members.  Data was not destroyed as the agency 
intended to continue participation in IPC in the future.  The parent agency for the clinic 
was committed to an ongoing quality improvement process that extended past the time of 
participation in the IPC.       
Summary 
 Chapter 3 encompassed a discussion of the methodology, evaluation research, 
used in this study.  Summative evaluation was the methodology used in the study.  An in-
depth description of the clinic and community illustrated its data collection process.  The 
chapter concluded with the data analysis plan with run charts for interpretation.  
Evaluation methodology was a valid method of research and assisted in determining the 
effectiveness of the IPC program. 
Chapter 4 is a presentation of the results from the data collected on the IPC 
measures, as well as the collaborative results for both process and outcome measures.  
The process measures include such items as screening for domestic violence and other 
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preventive care screenings.  Outcome measures include control of blood pressure, control 
of lipids and control of HgbA1c.   
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Chapter 4: Results  
Introduction 
The purpose of this study was to evaluate the process and selected patient 
outcome measures as part of participation in the IHS IPC collaborative for a small tribal 
health organization.  In this chapter, I report the data that represent patient care changes 
that occurred as a result of UWC’s participation in the IPC.  Changes in patient outcomes 
(e.g., the increased percentage of patients who had HgbA1C and BP brought under 
control) were among the measurable indicators that served as the basis for the evaluation.   
Process changes included the number of individuals screened for depression and other 
preventive screenings.  Overall, this study was an assessment of whether the organization 
was able to meet its goals, defined at the beginning of the participation in IHS/IPC.   
This collaborative took place over a 15-month period between 2011 and 2012.  
Data collection began 3 months into the collaborative and continued for the period of the 
collaborative.  The resulting archived data represented 13 process measures and three 
patient outcome measures, specifically analyzed with the results presented in this chapter.  
Guiding the data analysis were two research questions: 
1. Did participation in the IPC improve care at the clinic?  
2. What was the impact of the IPC collaborative on identified process and 
outcome goals?  
The findings in this chapter were to demonstrate the outcomes of participating in 
the IHS patient care improvement collaborative.   
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Demographics 
 
The clinic participated in the IPC collaborative with individuals in each of the 
measures varying according to the measure.  The patient population also varied according 
to appropriate age range and number of patients who met the collaborative definition for 
each category.  Some of the measures, such as BMI, included patients as young as 2 
years.  Other measures, such as colorectal cancer screening, started at age 51.   
Table 2  
 
UWC Clinic Demographics (2011-2012) 
 
Sex  
Female 57% 
Male 43% 
Age  
Age 0-9           
Age 10-19 
Age 20-29 
Age 30-39 
1% 
12% 
17% 
18% 
Age 40-49 18% 
Age 50-59 11% 
Age 60-69 16% 
Age 70-79 1% 
Age 80-89 1% 
Race  
American Indian/Alaska Native 100% 
 
The population of the clinic at the beginning of the collaborative numbered over 
350.  During the period of the collaborative, this number fluctuated slightly as families 
moved away from the area, passed away, or otherwise became inactive.  Table 2 provides 
the gender and age distribution of the population served by the clinic.  Females were the 
majority (57%) and adults 18-70 years represented 12.4% compared to 87.6% for ages 2-
17 years. 
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IPC Measures Description 
Measures for this study were in two basic groupings: process measures and 
patient outcome measures.  Process measures encompassed health risk screening 
including screening for obesity, screening for tobacco use, screening for DV/IPV, 
screening for depression, blood pressure screening, colorectal cancer screening, cervical 
cancer screening, breast cancer screening, and provision of tobacco cessation counseling 
for tobacco users.  Additional comprehensive diabetes screening was a process measure 
that required an individual with diabetes to receive a foot exam screening, blood pressure, 
nephropathy measurement (urine for microalbumin), retinal screening exam, and 
measurement of HgbA1c.  If a patient with diabetes did not receive all these screenings, 
they did not meet the measure.  Patient outcome measures were used to address chronic 
disease patient outcomes.  These measures included the percent of individuals with 
hypertension whose blood pressure was controlled, individuals with hyperlipidemia with 
lipids within normal, and individuals with diabetes whose A1c was in control.    
Results of Collaborative Process Measures 
The main research focus for this study was identifying the effects of the IPC 
collaborative on identified process and outcome goals.  The following section is a 
presentation of the results of the IPC process measures followed by the outcome 
measures.   See Table 3 for a summary of the process measures as collected from January 
2011 through December 2012.   
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Table 3  
  
Process Measures (January 2011-December 2012) 
 
Screening Measure 
 
IPC 
 Goal 
% Screened 
at Beginning 
% Screened 
at End 
Percent 
Improvement 
     
Body Mass Index 80% 80 % 96.5% 16.5% 
DV/IPV* 80% 7.9% 90% 82.1% 
Depression 80% 15.1% 99.3% 78.2% 
Alcohol misuse 80% 27.2% 95.9% 68.7% 
Blood pressure 80% 48.9% 93.9% 45% 
Tobacco use 80% 31.6% 85.5% 53.5% 
Colorectal screening 70% 25 % 60% 35% 
Cervical cancer screening 70% 36.5% 84.6% 58.1% 
Breast cancer screening 70% 35.7% 62.5% 26.8% 
Diabetes care 70% 13.1 % 60% 46.9% 
Tobacco counseling                 70% 36.5% 84.6% 58.1% 
*Note. Domestic Violence/intimate partner violence 
 
For the majority of these measures, the clinic staff began to see an increase in the 
percentage screenings in the third month of data tracking.  This change could be 
attributable to key staff individuals attending an IPC conference on the IPC goals, and 
subsequent weekly IPC teleconferences, and two follow up face-to-face IPC meetings.  
The only three process measures not to meet IPC goals were screening for colorectal 
cancer, breast cancer screening, and comprehensive diabetes screening, which required 
measurement of blood pressure, LDL, nephropathy screen, HgbA1C, a foot exam, and 
retinal eye exam. 
Body Mass Index –Screening for Obesity 
At the beginning of the collaborative, only 49.1% of the clinic patients had a BMI 
measured.  Although the clinic was obtaining weights on patients at most visits, heights 
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were missing.  A steady increase in BMI began from the third month of the collaborative 
(See Figure 5).   
 
Figure 5. Percent of patients screened for BMI (2011-2012) 
 
This difference can be attributed to key staff members attending an IPC  
learning session and being oriented to IPC goals.  All staff shared these goals with a 
concerted effort to get BMIs entered for the majority of patients coming to the clinic.  
The clinic had been measuring weight, but had been inconsistent in getting heights for 
patients.  Clinic processes were changed to measure a patient’s height at least once a 
year.  As a result of the change in clinic processes, the clinic met the collaborative goal of 
80% of the patients being assessed for BMI.  These data provided answers the research 
question: How did participation in the collaborative impact selected process goals? 
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Domestic Violence/Intimate Partner Violence Screening  
The measure with the lowest starting score was DV/IPV.  The DV/IPV screening 
questions proved difficult for the staff to ask because they were asking personal questions 
of family members and friends.  In the fourth month of the collaborative, the institution 
of a three-part paper questionnaire became part of a PDSA process to help improve 
collection of data.  The tool included questions about alcohol use, depression, tobacco 
use, and DV/IPV (see Appendix E).  The provider handed this form to the patient and 
entered the results into the system.  Although progress occurred toward the goal, the 
clinic was still short of reaching the goal.  In another PDSA cycle, the front desk at 
check-in handed out the survey with the results entered by the receptionist.   
During the fifth through eighth months, a steady increase was noticeable in the 
percentage of screened patients.  At the end of the eighth month of the collaborative, the 
front desk receptionist resigned, and a series of temporary individuals covered the 
position.  As a result, the surveys were not consistently handed out, and the percent of 
individuals screened dropped from 66% screened to 41% screened.  By the end of the 
eleventh month, the front desk position was permanently filled, and the routine of 
handing out the surveys at check-in was once more established, and screening continued 
to improve (See Figure 6).   In a subsequent PDSA the case manager entered the results 
of the screening and the clinic was able to meet the goal in the 12th month of the 
collaborative.   
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Figure 6. Percent of females aged 15-40 screened for DV/IPV (2011-2012) 
 
Depression Screening 
At the beginning of the collaborative the clinic staff screened about 15% of 
patients over the age of 18 for depression.  This measure proved be a difficult for the 
clinic staff because they were asking family and friends sensitive questions.  Originally, 
the screening occurred face-to-face with the person rooming the patient asking the 
questions.  By four months into the collaborative no change was made in the percentage 
of patients screened for depression.   
A PDSA cycle discussed in the paragraph above was instituted and involved the 
use of a paper screening form with two depression questions (a) Over the past two weeks 
have you felt down, depressed or hopeless (yes or no), and (b) Do you ever feel little 
interest or pleasure in doing things (yes or no).  This form was handed to the patient by 
the provider and results were entered by the provider.  Although movement toward 
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improving the percentage of patients screened for depression, the clinic still had not 
reached collaborative goals.   
In another PDSA cycle the receptionist at the front desk distributed the 
questionnaire at time of patient check-in at the clinic.  The patient then completed the 
questionnaire after being placed in the exam room, while waiting for the provider.  The 
questionnaire was then handed back to the receptionist who then entered the results.  As 
discussed in the paragraph on IPV/DV screening, the front desk receptionist resigned and 
as series of fill-in receptionists worked the front desk.  As a result, inconsistency occurred 
in handing out the questionnaire and in entry of the results.  In a subsequent PDSA cycle, 
the case manager then entered the results of the screening into the electronic health 
record.  This practice steadily increased the documentation of screening.   
 By the end of the collaborative, over 93% of individuals completed the screening 
questionnaire for depression and the results of the screenings were entered into the 
electronic health record. (See Figure 7).  Changes in clinic processes and use of tools 
provided by the IPC were instrumental in the clinic meeting this goal.  This data provided 
an answer to the research question: What impact did IPC have on selected process goals?   
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Figure 7. Percent of active patients over age 18 screened for depression (2011-2012) 
 
Alcohol Misuse Screening 
The following data were the results for the research question: What was the 
impact of participation in IPC on selected process measures.  At the beginning of the 
collaborative only 27.2% of patients were screened for alcohol use.  As with the two 
other behavioral health measures, this question proved difficult for staff to ask of their 
family members and friends.  Numbers of individuals screened did not change much until 
the clinic instituted a paper screening form as described in the paragraphs above.  The 
changes included: Do you ever feel like you should cut down on your drinking? (yes or 
no) Do people annoy you by criticizing your drinking? (yes or no) Do you ever feel bad 
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or guilty about your drinking? (yes or no) Do you ever have a drink first thing in the 
morning to steady your nerves or get rid of a hangover? (yes or no).     
The front desk receptionist handed out the questionnaire at patient check-in.   The 
patient then filled in the screening questionnaire while waiting for the provider to come 
into the room.  Initially, the provider entered the results. In subsequent PDSAs the 
receptionist entered the results and in the final PDSA for this measure the case manager 
entered the results of the screening into the electronic health record.  After implementing 
screening at the time of check-in, the numbers screened steadily increased and by the end 
of the collaborative the clinic staff had screened 95.9 % of the patients (See Figure 8).  
The clinic met the collaborative goal of screening 80% of their patients for alcohol 
misuse.  Use of PDSA cycles and tools provided by the collaborative were instrumental 
in the clinic meeting the goal for this measure. 
 
Figure 8. Percent of patients ages 12-75 screened for alcohol misuse (2011-2012) 
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Blood Pressure Screening 
At the beginning of the collaborative, only 48% of patients had blood pressure 
screening.  The numbers started increasing rapidly after the third month of the 
collaborative.  This increase started after key members of the clinic attended the first IPC 
face to face learning session that reviewed collaborative goals for screening.  These goals 
were reinforced at two subsequent IPC face-to-face learning sessions.  In addition to 
learning about IPC goals the clinic team stove to improve their number out of a sense of 
friendly competition.  At monthly IPC meetings via Adobe Connect with other teams 
across the Indian Health Service, the IPC National team verbally recognized teams who 
achieved specific IPC goals or made the greatest improvement.  The clinic staff also had 
the opportunity to showcase clinic screening and patient outcome improvements in a 
poster session at each of the face-to-face trainings. 
At the beginning of the collaborative the staff had not been consistent in getting 
blood pressures.  After learning collaborative goals, clinic procedure for checking in a 
patient changed and blood pressures became a requirement at every visit unless the 
patient specifically refused a blood pressure.  When patients became educated on the 
purpose of measuring blood pressures and the clinic participation in the collaborative, 
few refused the blood pressure screening.  After the third month the clinic met the 
collaborative goal of blood pressure screening at least 80% of patients coming into the 
clinic (See Figure 9).  
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Figure 9.  Percent of Patients over Age 20 with BP Screening (2011-2012). 
 For this particular measure, learning collaborative goals and a change in clinic 
process were key to improving screening across the length of the collaborative for blood 
pressure.  This data point provided the data answers the research question: What was the 
impact of participating in the IPC on selected process measures?  Although this particular 
measure improved after clinic personnel were oriented to the IPC process, this was not 
the same for all measures as will be discussed later in this study. 
Tobacco Screening 
Data from this measure answers the research question as to which process 
measures met IPC goals.  At the beginning of the collaborative 31.6 percent of active 
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patient screened for tobacco use during the collaborative (See Figure 10).   At the end of 
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the collaborative 85.5 % of active clinic users were screened for tobacco use, an increase 
of 53.9 %.   
 
 
Figure 10. Percent of patients screened for tobacco use (2011-2012) 
 
 Providers were responsible for collecting tobacco use data at the beginning of the 
collaborative.  This procedure proved to be an unreliable method of gathering data.  The 
providers had reminders turned on in the electronic health record during the early part of 
the collaborative, but were inconsistent in using them and in documenting patient 
responses.   Reminders were a little box at the top of the patient’s electronic health 
record.   
 In one PDSA cycle, the clinic tested a paper survey, handed to patients at check-
in.  The provider was then responsible to enter the data.  Although this initially increased 
screening for tobacco use from the 4th month of the collaborative to the 10th month of the 
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collaborative, the screened percentage remained about the same.  In another PDSA, the 
case manager entered the responses into the electronic health record with the result of a 
steady increase in the number of individuals screened for tobacco use.   
Through the use of multiple PDSA cycles the clinic process of collecting tobacco 
use data was modified and the number of individuals screened for tobacco use steadily 
increased.  The clinic met the collaborative goal of screening 80 percent of active clinical 
users the last three months of the collaborative. 
Cancer Screening 
Cancer screening process measures answers both research questions as to 
whether the clinic improved care and what process measures met IPC goals.  The cancer 
screening process measures included colorectal screening, cervical cancer screening and 
breast cancer screening.  These measures were also among the lowest percent of screened 
at the beginning of the collaborative.  Of the three cancer screening processes only 
cervical cancer screening reached the IPC goal of 70% (See Table 3).  The colorectal 
screening (colonoscopy) and breast cancer screening (mammogram) took place at a 
hospital 800 miles from the clinic, which created challenges in case management to meet 
the collaborative goals.  Case management will be discussed further in the following 
paragraphs. 
Colorectal Screening 
At the beginning of the collaborative, the clinic screened 25%t of patients (aged 
51-80) for colorectal cancer.  By the end of the collaborative, the percentage increased to 
60%, an increase of 35%.  The clinic did not achieve the collaborative goal of 70% of the 
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active population being screened for colorectal cancer.  However, staff did get closer to 
the collaborative goal of 70% screening in fourth and sixth month of the collaborative 
with 64.3% and 66.7% respectively getting screened (see Figure 11).   
 
 
 
Figure 11. Percent of men and women current on colorectal screening (2011-2012) 
 
Although the collaborative allowed the use of fecal occult blood (FOB), such as 
Hemocult, to meet this measure, the staff chose not to use this method to meet the goal.  
FOB analysis often produced a high incidence of false positive results due to a high 
intake of red meat, such as seal and whale and high rates of h pylori, possibly causing 
inflammation and bleeding in the stomach.  The local population ate a large amount of 
marine mammals and also had high rates of h pylori making the FOB tests available at 
that time insensitive as a colorectal cancer screen.  Also, the clinic staff decided not to 
use flexible sigmoidoscopies that do not visualize the right colon.   
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Prior to the collaborative, two patients had a diagnosis of adenomas of the right 
colon, which could not be identified with a flexible sigmoidoscopy.  Because of these 
factors, staff believed that all patients should receive a screening of the entire colon.  
Colonoscopies were not available on island due to issues around anesthesia.  Patients 
were required to fly to the referral hospital 800 miles distant to get this screening.  When 
the patient returned from the referral hospital the results were entered into the electronic 
health record and the measure was met for that particular patient. 
  Major barriers to completing colorectal screening existed.  These barriers 
included distance traveled, time away from work (a minimum of three days), and fear of 
flying due to past bad experiences.  Additionally, patients also reported previous bad 
experiences with the procedure, fear of pain, and embarrassment.  PDSAs for community 
awareness about colorectal cancer were effective at increasing the number of persons 
who agreed to travel for screening.  Additionally, improvements in the electronic health 
record, and provider training in the use of population management tools were also helpful 
in tracking, and identifying individuals in need of screening.  Provider training in 
motivational interviewing was also instrumental in the increased rates of individuals who 
traveled for colorectal cancer screening (See Figure 11).   
The electronic health record was updated once the patient returned from the 
colorectal screening with the results.  The measure for colorectal screening was satisfied 
with the entry of the results.  If the results were not entered, the electronic health record 
showed that the patient was still due for the colonoscopy.  Although many PDSA cycles 
were attempted, support systems changes were made, and provider trainings on 
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motivational interviewing to encourage patients to get a colonoscopy proved helpful to 
increase the number of individuals who traveled for colorectal screening, the clinic was 
not successful at meeting the collaborative goals.  The clinic did not meet this measure 
due having to use outside resources off island.   
Cervical Cancer Screening 
The data for this screening provided answers to the question about what process 
measures met IPC goals.  At the beginning of the collaborative 36.5 % of women, ages 
21-64, had screenings for cervical cancer.  At the end of the collaborative, 84.5 % of 
women received screenings for cervical cancer, an increase of 48 %.  The clinic met the 
collaborative goal of screening 70 % for women (aged 21-64) for cervical cancer in the 
fourth month of the collaborative and then in the eleventh through fourteenth months of 
the collaborative (See Figure 12). 
.  
  
Figure 12. Percent of women (Aged 21-64) screened for cervical cancer (2011-2012) 
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The clinic did not achieve the IPC goal of 70 % screening in the first three months 
of the collaborative, because of the lack of consistency in identifying women needing 
cervical cancer screening and getting them to come for the screening.  An overall 
improvement occurred from the beginning of the collaborative where the clinic started at 
only 35.7%, screened to 62.5% in the final month of the collaborative, an increase of 
26.8%.  The staff did not consistently meet the goal of screening 70% of women for 
cervical cancer. 
The spike in number of cervical cancer screenings in the fourth month of the 
collaborative was due to the clinic bringing in a women’s health care provider from 
outside of the community to perform cervical cancer treatment.  A number of women did 
not want their cervical cancer screening done by someone whom they saw daily in social 
situations (e.g., the store or community gatherings).  In April a women’s health care 
provider from outside the community came to the clinic with the result that more women 
due for cervical cancer screening had those screenings done.  The next month the number 
screened dropped because no outside provider was available.   
 In the fifth month of the collaborative, the clinic case manager began using iCare, 
a population health care management software program, to collect names of individuals 
due to have a cervical cancer screening.  Patients received mailed reminder cards about 
coming to the clinic for cervical cancer screening.  Although this reminder initially did 
not seem to impact numbers, eventually women started coming in for their cervical 
cancer screening.  The clinic also coordinated with the referral hospital to arrange for 
cervical cancer screening at the same time the women had their mammogram.  This 
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coordinated effort of using outside providers, population management tools and sending 
reminders lead to improved screening rates.   
Breast Cancer Screening   
The data for breast cancer screening provided data for determining which process 
measures met IPC goals.  The staff did not reach the IPC goal of 70% screening in two 
months of the collaborative, because of the lack of consistency in reminding women 
about the screening and actually doing the screening (See Figure 11).  The staff was 
screening 35.7% of women for breast cancer at the beginning of the collaborative.  
Implementing population management tools, making better use of local resources, and 
improved processes increased the screening rate to 62.5% of women, an improvement of 
26.8%.   
This measure had the least improvement.  The data points were not consistent and 
showed no clear pattern of improvement.  Using the rules of run chart interpretation, the 
researcher cannot say that there was an improvement in this measure.  The staff did not 
meet the goal of screening 70% of women for breast cancer by the end of the 
collaborative.   
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Figure 13. Percent of women screened for breast cancer (2011-2012) 
 
In the fourth month of the collaborative, the large increase in the number of breast 
cancer screening related to a visiting women’s health care provider who did cervical 
cancer screening, including a clinical breast exam.   An appointment for a mammogram 
might not be requested at the referral hospital until they received a clinical breast exam 
results form.   When women returned from the referral hospital, the results of the 
mammogram were entered into the electronic health record which satisfied that measure. 
In the UWC health care system, women had two choices for mammograms.  
Women could either (a) travel off island to Anchorage for a mammogram or (b) wait for 
the mammogram van each year in the fall on the ferry.  The tribally-operated hospital 
paid for travel and for housing for women needing to travel to Anchorage for their 
mammogram.   
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The spikes in screening in the fourth month and the eleventh month coincided 
with the visiting women’s health care provider and the mammogram van arrival on the 
ferry.  Additionally, population management tools and provider reminders, initiated in the 
clinic, improved the screening numbers.    
 Two additional prevention process measures are part of the data answering the 
research question: What was the impact of IPC participation on selected process 
measures?  These measures included diabetes comprehensive care and tobacco user 
cessation counseling.  The tobacco cessation counseling process measure required that a 
patient, identified as a tobacco user, receive tobacco cessation counseling within the last 
year.  The clinic met one collaborative goal for chronic disease prevention, but not the 
other.  
Diabetes Comprehensive Care 
 Diabetes comprehensive care was a process measure, requiring a patient with 
diabetes to have a documented annual A1C, blood pressure, LDL, nephropathy 
assessment, retinal screen, and foot exam.  If any of the elements were missing the 
measure was not met.  At the beginning of the collaborative, 11.8% of patients with 
diabetes had their documentation at some point in the last year (See Figure 14).   
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Figure 146. Percent of diabetic patients with documented A1C, BP, LDL, nephropathy 
assessment, retinal screen & foot exams (2011-2012) 
From the eleventh month to the end of the collaborative, the clinic staff saw a 
steady increase in the percentage of individuals who completed all of their diabetes 
comprehensive care screens, labs and, exams   However, by the end of the collaborative 
only 60% (an increase of 47.2 %) with diabetes had documented A1C, blood pressure, 
LDL, nephropathy assessment, retinal screen, and foot exams in the last year. The staff 
did not reach the collaborative goal of 70% of patients with diabetes completing all their 
comprehensive care components.   
This measure was not met because the clinic did not have either professional or 
technical resources to meet the goal.  Many PDSA cycles were attempted to meet this 
measure, but none were successful.  In the ninth month of the collaborative, the 
screenings started to rise due to (a) improving case management at the clinic and (b) 
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scheduling dilated eye exams when individuals were going to travel to Anchorage for 
other health care problems.  Although a trend began toward meeting the measure, the 
staff fell short of the collaborative goal of 70% of patients with diabetes completing all 
their comprehensive care components.   
Tobacco Cessation 
This measure provided data for the research question: What was the impact of 
participation in the IPC on selected process measures?  No tobacco cessation data was 
collected in the first two months of the collaborative.  At the beginning of the 
collaborative 17.6 % of active clinical patients using tobacco received tobacco cessation 
counseling.  A downward trend occurred in the fifth to ninth months of the collaborative 
(See Figure 15).   At the end of the collaborative, 66.7% of tobacco users had tobacco 
cessation counseling, an increase of 49.1%.   
 
 
Figure 15. Percent of patient who received tobacco cessation counseling (2011-2012) 
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Improvements in this measure in the 10th month of the collaborative were as a 
result of provider education and process improvement in addressing the tobacco cessation 
goal. The clinic staff met the collaborative goal of counseling 70% of tobacco users to 
quit only one month during the collaborative.   
Results of Collaborative Patient Outcome Measures 
 The following section presents data to answer the research question as to what 
outcome measures showed improvement.  Outcome measures included: control of blood 
pressure (BP), control of lipids and control of Hgb A1C.  Of the outcome measures the 
clinic only met the collaborative goal for lipids (See Table 4). 
 
Table 4  
 
Outcome Measures for Chronic Conditions 
 
Measure 
 
IPC Goal % Screened 
at Entry 
% Screened 
at End 
Percent 
Improvement 
Control of BP 70% 13.1  60 46.9 
Control of Lipids 70% 36.5 84.6 58.1 
Control of Hgb A1C 70% 35.7 62.5 26.8 
  
  
Control of Blood Pressure 
At the beginning of the collaborative, 13.1 % of patients with hypertension had 
controlled blood pressure.  At the end of the collaborative 57.5% of those with 
hypertension had controlled blood pressure, an increase of 44% (See Figure 16).  This 
dramatic increase occurred for patients with blood pressure in control began in the third 
month of the collaborative and was associated with a change in the process for patients 
who came into the clinic with an elevated blood pressure.  Their pressure was checked 
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again at the end of the visit.  However, even with these changes in procedure in 
measuring blood pressure, the clinic did not meet the collaborative goal of 70% of 
patients having their blood pressure under control.     
 
 
Figure 16.  Percent of diabetic patients with BP < 130/80 or a diagnosis of hypertension 
& BP < 140/90 in 2011-2012 
 
The implementation of the clinic process change was in the third month of the 
collaborative with a large increase in blood pressures under control.  However, after that 
initial improvement, the numbers in control leveled off.  The majority of reasons for not 
meeting this measure were a result of patients misunderstanding their medication 
instructions.  Patients thought that they had to eat first in order to take their blood 
pressure medications.  When they came in for their fasting lab work, they had not eaten 
and not taken their medication.  The result was elevated blood pressure readings.  Also 
many patients waited until they were out of their medication before coming in for a refill.  
Again, the result was an individual with an elevated blood pressure.  Changing years of 
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habits proved difficult.  Getting patients to come back for re-check of their blood pressure 
also was challenging.  Although the clinic staff attempted to improve the clinic process, 
the collaborative goal of 70 %t of patients with blood pressure control was not 
achievable. 
Control of Lipids 
At the beginning of the collaborative, only 4.2% of the patients had their LDL 
measured and were in control.  A downward trend in data occurred from the sixth to the 
ninth month of the collaborative.  Inconsistent data entry for labs into the electronic 
health record accounted for the low initial numbers and the dip in data (See Figure 17).  
In the sixth month of the collaborative the clinic lost a key individual who was entering 
lab data.  With fewer results being entered into the electronic health record, any abnormal 
value that did get entered was enough to decrease the percent of patients whose LDL was 
in control.  
 At the end of the collaborative, 80% of individuals received screenings.  The 
following statements made by measured LDLs were in control, an increase of 75.8%.  
The number in control between the 9th and 11th months probably more accurately 
reflected data entry issues, rather than actual LDL in control.  The clinic met the 
collaborative goal of 70% in the last three months of the collaborative.   
71 
 
 
 
Figure 17. Percent of individuals on cholesterol lowering medications with controlled 
LDL (2011-2012) 
 
Control of HgbA1c   
The data for this measure provided answers for both research questions: Did 
patient care improve at the clinic and also the question; what outcome measures met 
collaborative goals?  As part of negotiated services with our referral hospital, a diabetes 
team from the tribally-operated hospital in Anchorage traveled annually to the clinic to 
provide a diabetes clinic.  The team worked with the local clinic staff to manage 
medications, as well as providing podiatry services and nutrition counseling.   
Prior to the visit the clinic had all diabetics come in for blood drawing.  The UWC 
saw patients with diabetes at other times of the year, but this visit was an opportunity for 
the patient to see a specialist in diabetes care.  No measurement of HbgA1cs was 
available in the sixth and seventh months of the collaborative (See Figure 18).  This data 
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mission occurred because patients were busy during the summer months with fishing and 
other subsistence activities.     
Only 21 individuals with type II diabetes were in the clinic population.  Because 
of this small numbers, a few individuals with out of control significantly HgbA1C 
affected the rest of the group.  Improvement after September of the collaborative year 
reflected the visit of the diabetes team when medication adjustments took place. (See 
Figure 18)   
With a variety of provider education sessions on patient self-management training 
and data entry improvements assisted the clinic staff to meet the collaborative goal of 
70% of the diabetic patients with HgbA1C in control the last two months of the 
collaborative.  Using the rules of run chart interpretation (Provost & Murray, 2011), I 
cannot say that the improvement in meeting the goals was due to more than chance.  I can 
say that there was a trend toward improvement.  More data points past the end of the 
collaborative would be needed to see if the trend continued or dipped back down past the 
median.     
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Figure 18. Percent of diabetic patients with HgbA1C less than 7 (2011-2012) 
Summary 
Data from the IPC collaborative indicated positive change. The areas of greatest 
improvement for process measures were in screening for depression and intimate partner 
violence with 82.1% and 78.2% improvement respectively.  Both measures met 
collaborative goals of screening 80% of the eligible patient population.  Although 
screening for body mass index improved somewhat (16.5%), the clinic screened over 
80% of the patients for BMI during the entire duration of the collaborative.  The process 
measures screening for DV/IPV, depression, alcohol misuse, tobacco use, cervical cancer 
screening, and tobacco cessation counseling all increased to rates of over 50%.  
 Other process measures (i.e., screening for blood pressure and diabetes) had 
increases of 45% and 46.9 % respectively.  Process measures showing the least 
improvement were colorectal (35%) and breast cancer (26.8%) screenings.   
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The following process screening measures all met collaborative goals of 80%: 
obesity DV/IPV, depression, alcohol misuse, blood pressure, tobacco use, cervical 
cancer, and tobacco cessation counseling.  Three measures did not meet the collaborative 
goal of 70% screening: colorectal cancer screening, breast cancer screening, and 
comprehensive diabetes care.   
Patient outcome measures likewise had mixed results.   Although the clinic met 
the collaborative goals, control of lipids had an improvement of 58.1% and was the only 
outcome measure to meet the collaborative goal of 70%.  Control of HgbA1C had the 
lowest improvement at 26.8%.  Control of blood pressure had an improvement of 46.9% 
at the end of the collaborative.  Control of blood pressure or HgbA1C met the 
collaborative goal of 70%.   
Chapter 5 is a presentation and discussion of the study findings and conclusions 
along with study limitations and recommendations for future research in this area.   
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    Chapter 5: Discussion, Conclusions, and Recommendations 
A Brief Overview of the Study 
This study was an evaluation of the impact of participation in the IHS IPC 
collaborative for a small tribal health organization.  The framework for this study was the 
chronic care model.  Providing quality health care for individuals with chronic disease 
was important in preventing complications and their progression (Clark et al., 2011; 
Cohen et al., 2004; Wagner et al., 2001).  Yet, oftentimes patients did not get the care that 
they need (Bodenheimer, 2003; Duckers, Wagner, & Groenewegen, 2008; Hroscikoski et 
al., 2006).  Disparities in chronic diseases existed between the overall U.S. population 
and Native American people (Acton, 2002; Amparo, Far, & Dietz, 2011; IHS, 2013; 
Sequist et al., 2010).  
 To address these disparities, the IHS partnered with the Institute for Health Care 
Improvement to develop a quality improvement patient care collaborative.  The goals of 
the collaborative were to provide high quality, coordinated care and promote measurable 
changes within the system (IHS, 2012).    Patient care improvement collaboratives have 
been widely used method to improve health care practices in the United States (Grossman 
et al., 2008).  The QWC took part in the IPC collaborative over a period of 15 months in 
2011-2012. 
The purpose of this study was to determine whether participation in the IHS IPC 
collaborative improved identified patient care processes and outcomes.  The principal 
research question for the study was the following: Did participation in the IPC improve 
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the delivery of care and outcomes at the clinic?  The associated questions included the 
following: 
1. What criteria did the organization use to measure the success of the 
implementation? 
2. What was the effect of this implementation on the organization’s 
performance? 
Summary and Interpretation of Findings 
Using an evaluation methodology, run charts were the instruments for collecting 
data and determining whether clinic staff met the collaborative goals for the identified 
measures.  Archived data stored in RPMS collected during participation in the 
collaborative was the data source for analysis.  The results of the study were as follows.  
All of the preventive screening process measures (i.e. documentation of BMI, domestic 
violence screen, depression screen, alcohol screen, tobacco use, and blood pressure 
screen) improved and met collaborative goals.  However, for cancer screening (i.e., 
colorectal, cervical, breast) the clinic met the collaborative goals only for cervical cancer 
screening.  The clinic did not meet collaborative goals for colorectal or breast cancer 
screening.   
For the patient care process measure for comprehensive diabetic care assessment 
(i.e., Hgb A1C measured, BP measured, LDL measured, nephropathy assessed, retinal 
exam, and foot exam), the clinic did not meet the collaborative goal of 70%.  The clinic 
staff also did not meet the goal for tobacco cessation counseling.  For patient outcome 
measures (control of blood pressure, lipids, and Hgb A1c), the clinic met collaborative 
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goal only for lipid control.  The clinic did not meet the goal for control of either blood 
pressure or Hgb A1C.   
The process measures that met collaborative goals involved the use of PDSAs to 
improve clinic processes in collecting and documentation of patient screening results.  
Those process measures that did not meet collaborative goals required the use of external 
resources such as dilated eye exam, colonoscopies and mammograms.  Patient outcome 
measures, not meeting the collaborative goals, were due to issues around patient self-
management. 
Discussion of Results 
Process Measures for Health Risk Screening 
Process measures in this evaluation included health risk screening, cancer 
screening, tobacco cessation counseling, and comprehensive diabetes care.  According to 
the findings of the evaluation, the clinic met all of the collaborative process measures 
goals for preventive screenings.  Polacsek et al. (2009) had similar conclusions that 
participation in a health care improvement collaborative improved process outcomes.  
The improvement in process outcomes was also similar.to studies by Mangione-Smith et 
al. (2005) and Landen et al. (2007).  These positive findings were at odds with the study 
by Shaw, Chase, Howard, Nujtting, and Crabtree (2012), who found that participation in 
a health care improvement collaborative resulted in minimal changes in clinic processes. 
The preventive measures process goals for this study included BMI assessment, 
domestic violence screening, depression screening, alcohol misuse screening, blood 
pressure screening, and tobacco use screening.  The clinic met all of these measures 
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through the use of PDSA cycles, which lead to changes in clinic processes (e.g., the 
institution of paper questionnaires to survey sensitive personal questions).  The collection 
of this sensitive information became routine, and patients were willing to answer these 
questions on paper.  For blood pressure screening, the measure was met because the 
clinic changed their protocol to require a blood pressure at each visit.  The clinic was able 
to meet preventive screening goals through the use of PDSA cycles from the model for 
improvement.  Incorporating the model for improvement into clinic processes lead to 
improved numbers of individuals screened for these issues.   
For the provider who approaches patient care based on the chronic care model, the 
hope is that screening will help the provider identify issues that lead to chronic disease.  
The provider then works collaboratively with the patient to set goals for addressing areas 
of concern.  For example, the patient with the increased BMI can be referred to the 
nutritionist or given a pass to the local recreation center or pool to increase their physical 
activity level.  The patient with positive DV/IPV, depression, or alcohol misuse screening 
can be referred for counseling or connected with the appropriate resources.   
Process Measures for Cancer Screening 
Cancer screening process measure goals in this study were met for cervical cancer 
screening, but not for colorectal or breast cancer screening.  While cervical cancer 
screening was available at the clinic, screening for colorectal and breast cancer screening 
was available only at a facility 800 miles from the clinic.   
Cervical cancer screening is performed to identify HPV which is the leading 
cause of cervical cancer.  Caught at an early stage, it can be easily treated.  The cervical 
79 
 
cancer screening measure was met primarily due to the use of a provider from outside of 
the community.  This provided women who were concerned about receiving this exam 
from local providers an alternative.  Additionally, the clinic used case management and 
population management tools to increase the amount of women receiving cervical cancer 
screening.  These methods are core to the chronic care model as modified by the IHS. 
For colon cancer screening, the main reason for not reaching collaborative goals 
and making very little improvement was due to lack of local access to the screening.  
This finding was similar to a study by Gupta et al. (2009, in that access to care was the 
main predictor of participation in colon cancer screening.  In this part of Alaska, although 
colon cancer screening was available at no cost to eligible American Indian and Alaska 
Native individuals, access to care for colon cancer screening was difficult due to long 
distances to travel for these services.   
Barron et al. (2008) found that reducing time and distance to screening increased 
participation in screening for colon cancer.  One option for increasing screening for 
colorectal cancer was to provide these services in the local community.  However, 
providing colonoscopies (the preferred method of screening for colon cancer in the 
Alaska Area IHS) was not feasible due to medical restrictions around anesthesia.  The 
surgery clinic at the referral facility in Anchorage offered to travel to the community to 
perform flexible sigmoidoscopies; however, this option would miss lesions of the 
ascending colon.   
Another low cost option involving no travel would be to screen by using the 
newer fecal occult blood testing.  This procedure requires the patient to collect a stool 
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specimen, place the sample on a card, and bring it to the clinic for the final step of testing 
for the presence of blood.  The newer fecal occult blood tests were more sensitive for 
blood coming from the intestine and did not have the same shortfalls of older hemocult 
tests.  However, Morikawa et al. (2005) found that fecal occult blood testing sensitivity 
could be relatively low depending on the location of the tumor.  O’Leary, Olynyk, 
Neville, and Platell (2003) found that a colonoscopy was the most effective for detecting 
colorectal cancer, followed by flexible sigmoidoscopy and then annual fecal occult blood 
testing.  This recommendation matches the preferred colorectal screening method for the 
providers at the clinic.   
The best use of available resources would be for the clinic to maximize case 
management by trying to get the most out of each trip to the referral facility.  When 
patients travel to Anchorage for other specialty clinic appointments, they could have an 
appointment also for a colonoscopy or mammogram to minimize family and work 
disruption.  Many patients travel to Anchorage for the annual Alaska Federation of 
Natives Conference or for their regional Alaska Native corporation meetings.  Scheduled 
appointments could be either before or after the conference.  
 Providers and case managers would need plan far in advance of these meetings as 
individuals from all over the state were also traveling in to Anchorage for the meetings 
and appointments at the referral hospital and slots fill up quickly.  In terms of breast 
cancer screening, similar issues also existed regarding access to care.  Although 
mammograms were available at the referral hospital 800 miles away, women were 
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sometimes reluctant to fly due to the time and distance involved and past experiences 
related to flying in bad weather.   
Doescher and Jackson (2009) found that rural women, particularly the elderly, 
were less likely to receive a mammogram than their urban counterpart.  Access to care 
was more difficult to address given the remoteness of the setting.  One option for 
addressing access to care for those women who were reluctant to fly or unable to take 
long periods off work would be to make use of the mobile mammogram van that travels 
to the island once a year.   
Process Measures for Chronic Disease 
Two other chronic disease process measures did not meet collaborative goals:    
tobacco cessation counseling and diabetes comprehensive care.  The clinic almost met the 
collaborative goal for tobacco cessation counseling, but fell short.  Continued 
improvement occurred as the clinic went through the collaborative.  Screening for 
tobacco use identified patients who can be offered tobacco cessation counseling or 
information on other resources for intervention. The clinic staff found that by asking this 
question at every visit, patients started at least thinking about quitting.   
Tobacco use in this area of Alaska was among the highest in the state with lung 
cancer the second leading cause of cancer among AI/AN in this region of Alaska. 
(ANTHC, 2015).  The high rates of tobacco use in the region caused the agency to give 
tobacco cessation activity a high priority.  PDSA cycles, provider education in 
motivational interviewing, and improved documentation of cessation all contributed to 
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the improvement.  Activities based on the chronic care model and the model for 
improvement were instrumental in the increased performance for this measure. 
For the comprehensive diabetes screening measure, one portion of the measure 
kept the clinic from meeting the goal, retinopathy screening to be performed at the 
referral hospital 800 miles distance from the clinic.  Screening the retina of individuals 
with diabetes helps to identify eye problems related to diabetes to be caught early and 
early intervention can prevent vision loss.  The measure was not met until the patient 
actually completed the screening, and the results were entered into the electronic health 
record.   
One option for meeting this goal was to make use of the IHS Joslin Vision 
Network (JVN) tele-ophthalmology program.  The IHS JVN program was a telemedicine 
program used through much of Indian country for the remote diagnosis and management 
of diabetic retinopathy.  This system involved a non-eye-dilating system that 
photographed the retina and sent the results electronically to experts for review.  
Researchers (e.g., Carrol et al., 2011) found this method of looking at the retina to be 
superior to in-person exams with an optometrist or ophthalmologist.  However, some 
techniques could be useful in training staff to use the system.   
The quality of the images of the JVN system depended on the skills of the 
individual using the camera.  The JVN program required providers, going to use the 
camera, to travel to Arizona for training.  Of particular note, the JVN program found that 
individuals who did not regularly use the camera lost the ability to take quality photos.  
The JVN program recommendation was that individuals take at least 100 retinal photos 
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each year to remain proficient. The requirement for off-site training was a barrier for the 
clinic.  With cuts in IHS budgets, no funding was available to send a staff member to 
Arizona for the training.   
In addition, fewer than 100 individuals with diabetes were in the entire agency, so 
keeping skills honed would be difficult.  Another possibility was to partner with a sister 
agency operating clinics in the next region for provision of the service.  The camera is 
provided by the JVN program at no cost to the tribal agencies.  Trips for retinopathy 
screening needed to be carefully coordinated because of the limited availability (i.e., only 
one camera) for the entire south west and south east region of Alaska.   
Patient Outcome Measures 
 Outcome measures were less successful than process measures with only lipids in 
control meeting the collaborative goal.  Control of BP and control of Hgb A1C did not 
meet the collaborative goal.  In a study over a period of two years Halladay et al. (2014) 
had similar findings with lipids.  A significant improvement occurred in LDL levels.  The 
results, however, had statistically significant improvement in blood pressure and HgbA1c 
control.  Their conclusion was that improvement occurred with four key factors: (a) a 
diabetes registry, (b) use of standardized care templates, (c) patient care protocols, and 
(d) self-management support systems.  
 The IHS IPC Collaborative did not recommend use of standardized care 
templates or patient protocols.  The collaborative mentors did recommend self-
management support systems as part of the chronic care model.  Classes on self-
management support were available at each of the three face-to-face IPC learning 
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sessions.  One provider at the UWC attended some of these self-management support 
classes.  The UWC had a diabetes registry and patient self-management support systems 
in place. Access to the diabetes registry and self-management tools were on site.  
 Additionally, the clinic had access to experts at the referral hospital via phone or 
tele video.  Although the electronic health record had standardized note templates, two 
recommended by the collaborative were missing: (a) diabetes and (b) patient care 
protocols.   Knight, Ford, Audehm, Colagiuri and Best (2012) found that participation in 
a diabetes care collaborative improved control over blood pressure, lipid l and HgbA1C 
levels.  However, undetermined was whether the improvements were due to improved 
systems changes (e.g., registry clean-up and accurate coding), improved team dynamics, 
or redesign of clinical care.   
Although the UWC saw some improvements in HgsA1c in control, they did not 
meet the goal.  This appeared to be due to issues around patient self-management.  As 
part of the chronic care model, self-management support was an important component 
and one that needed to be strengthened in the clinic.  
Chronic Care Model 
Using the chronic care model as a framework for data analysis of patient care for 
chronic diseases was useful for the majority of process measures.  Less certainty existed 
about the impact on chronic disease outcome.  Many unmet measures of collaborative 
goals made significant improvement. Possibly, if the period of evaluation was extended 
the outcome measures might have met the collaborative goal.   
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With the chronic care model and the model for improvement as the framework for 
improvement, the UWC met the majority of preventive screening measures.  The UWC 
incorporated principles of the IPC collaborative into their own yearly clinic self-
evaluation, the expectation was for each employee to develop at least one PDSA cycle 
during the year. Additionally, participation in the ongoing Quality and Innovation 
Learning Network was a requirement for every person working at the clinic.   
Conclusions 
Implications for Social Change and Recommendations 
Chronic disease remains a challenge for many American Indian and Alaska 
Native clinics.  Those clinics with small practices, limited resources, and geographical 
isolation have additional challenges.  Staff challenges include adequate staffing, training 
and appropriately assigning components of data collection, and entry into the electronic 
health record.  Patients face challenges, as well in learning to take responsibility for their 
own chronic health care issues.  
 Through such techniques as motivational interviewing and other self-
management support tools, a provider can work collaboratively with patients to prevent 
chronic disease complications.  Additionally, organizational changes to systems need to 
be adequate to meet needs.  Allowing the clinic personnel to make small, quick cycle 
changes to test new processes is important in the journey to improve patient care.  Even 
with limited resources and a small staff, positive changes can improve care for patients.  
In addition, successes on a small scale can then be shared with the rest of the agency and 
other organizations of similar size.  Others can learn from both UWC’s successes and 
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failures.  A program built on the chronic care model and using it for improvement can 
contribute to significant improvement in patient care.   
Data from this study related to professional practice in the following ways (See 
Figure 19).  An organization needs staff to have the will to improve.  Administrative 
support and participation in collaborative processes and methods is instrumental for 
support of clinic staff activities.  Consistent and adequate staffing is important to support 
collaborative activities and to meet collaborative goals.   
When staff is small, the loss of key personnel can lead to decreased data 
collection and data entry.  Improved processes, tested on s small scale, can then be spread 
throughout the agency and institutionalized.  Improved processes lead to improved 
screening for chronic disease and other health risks.  Improved screening is thought to 
lead to improved outcomes in chronic disease.   
Provider training is instrumental in improving understanding of the chronic care 
model and the tools used for patient self-management and improved management of 
chronic care conditions.  Strong case management is important when trying to coordinate 
resources that are outside of the clinic.  Use of population management tools and 
electronic health record enhancements such as chronic disease screening reminders all 
improve screening and access to appropriate resources.   
Maximizing resources, either within the agency or through partnering with other 
organizations also helps to improve screening for chronic disease.  All these methods 
have a basis both in the chronic disease model as modified by the Indian Health Service 
and through use of the model for improvement. 
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Figure 19. Relation of data for professional practice 
 
Limitations and Future Recommendations 
 One limitation on this study was using a tribally-operated clinic, so the findings 
may not be applicable to larger facilities.  Also at the completion of this 14 month study, 
it was unknown whether the results of participation in the collaborative were ongoing or 
tapered off after the collaborative ended.   
Recommendations for Action 
Recommendations flowing from this study would be to freely share both 
successes our failures with sister agencies in Alaska and smaller tribal groups across the 
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U.S., struggling with implementation of IPC.  The IHS developed a continuation of the 
IPC for those agencies who completed the collaborative.  Clinics may apply to participate 
in the Quality and Improvement Learning Network (QILN).  The QILN is more loosely 
structured with no face-to-face meetings, but with monthly learning and sharing calls.  
This program would be a platform for the clinic staff to share their experiences.   
For some items, such as measurement of blood pressure and screening for obesity, 
consistency in clinic procedure is helpful to improve the percentage of people screened.  
A standard clinic policy which requires weight and blood pressure at each visit results in 
patients expecting that these two measurements will be taken, and the majority of patients 
will consent to be weighted and have their blood pressure measured.   
To increase screening for items,such as depression, domestic violence, alcohol 
use, and tobacco use, a consistent method is also helpful.  Patients come to expect that 
these topics will be surveyed at least twice a year and become more comfortable in 
completing the surveys.  Once this routine becomes part of data collection in the clinic, 
many patients will not refuse the screening.  This standardized procedure has opened up 
dialogue with patients, too embarrassed or not knowing how to ask for help with their life 
issues.   
Recommendations for increasing cervical cancer screening in very small 
communities are twofold.  One is to offer the patient choices.  By bringing in an outside 
women’s health care provider, women, who may not want cervical cancer screening by 
someone whom they see in the community on a daily basis, may come in for screening.  
By having this visiting provider also do clinical breast exams, the pre-screening exam 
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required for referral for a mammogram can also be completed.  Additionally, the clinic 
needs to educate the community that providers working at the clinic are able to do the 
cervical cancer screening.  The other option is to coordinate cervical cancer screening to 
occur at the same time the patient is flown out for mammogram screening.  All of these 
approaches will help to improve cervical cancer screening rates.   
For those organizations who, due to isolation or rural location, must sent their 
patients to a remote facility for colorectal and breast cancer screening, we can offer a few 
insights.  Case management in these two instances is key.  Individuals needing the 
screening need identification, as well as resources to help meet the need.  Not every small 
clinic has access to Indian Health Service or tribally operated resources, such as paid 
patient travel and housing when being sent to a facility located away from their home 
town.    
If a visiting mammogram unit comes to the area, the clinic needs to do ommunity 
outreach and case management to get patients in for the screening.  Additionally, if 
patients travel to a remote referral facility for other procedures, a mammogram, or 
cervical cancer, or colorectal cancer screening appointments could potentially be added.  
Additionally, particularly for colorectal cancer screening, community outreach and 
culturally appropriate education is useful in increasing interest in obtaining screening.  
Also, provider training in motivational interviewing is also helpful to increase screening 
rates. 
Recommendations for action for patient outcome measures include the following.  
A change in measuring blood pressure from the beginning of the visit to the end of the 
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visit resulted in increases in blood pressure in control.  This modification allowed a 
patient to relax, lowering the blood pressure.  In terms of HgbA1c in control, the number 
of individuals in the study with diabetes was too small to make any firm 
recommendations.  It appears that involving a diabetes team of experts might be helpful 
in improving A1C in control.  
Recommendations for action in terms of control of lipids involve both data entry 
and provider education.  By assigning lab data entry to one individual (in those clinics 
without a lab on site), data entry is improved.  Provider education on motivational 
interviewing and understanding of lipid management is also a key aspect to lowering 
lipids.   
The study results were shared with the parent agency health board at agency 
board meetings and further disseminated to the community during a tribal gathering.  
Results are available for reading by anyone coming to the clinic.   
Recommendations for Further Study 
Further study is needed on the on-going data collection after completion of the 
IPC collaborative.  The clinic transitioned to the Quality and Innovation Learning 
Network, a continuation of the processes learned in the collaborative.  The monthly 
teleconferences continued, but no face-to-face meetings.  Further study could evaluate 
whether the changes were permanent or just reflected participation in the IPC 
collaborative. Additional study could determine ways to improve diabetes care outcomes.  
What more would be needed to help patients reach their BP and HgbA1c goals?  
91 
 
For the behavioral health screening items, depression, DV/IPC, and alcohol 
misuse, future studies could focus on how many of the positive screens did receive a 
referral to behavioral health and whether the patients actually received the service.   
Assumed is that positive screening leads to referrals, but this study did not investigate 
that data.   
The results of this study offer new information about the effect of participation in 
a patient care improvement collaborative in a small tribally run clinic.  One unique aspect 
of this collaborative was the scope of the collaborative.  The majority of health care 
collaboratives focused on one or a few outcomes or processes (Nadeem, Olin, Hill, 
Hoagwood, & Horwitz, 2013).   The IHS IPC Collaborative covered 14 measures and 
focused on improvement across the entire organization from leadership to those 
providing direct patient care in the clinic.  
In conclusion, the IHS IPC Collaborative was effective in assisting the clinic staff 
to meet the majority of the collaborative goals.  By participating in the collaborative the 
UWC was able to improve many patient care processes and some patient outcomes.  
Although the clinic did not meet the collaborative goals for breast cancer screening, colon 
cancer screening, and blood pressure control, or HgbA1c in control, there were 
improvements the number screened and in control.   
The evaluation enabled the researcher to identify and document changes in care 
provided at the clinic during the patient care collaborative.  A variety of methods (e.g., 
case management, electronic health record enhancements, paper based questionnaires, 
provider training in motivational interviewing and other processes recommended by the 
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IPC collaborative for improvement) were useful during PDSA cycles.  Through PDSA 
cycles based on Deming’s model for improvement and the chronic care model with 
proper support and adequate staffing, improvements occurred in patient care processes, 
and in one patient outcome.     
 
  
93 
 
References 
Acton K., Burrows, N., Moore, K., Querec, L., Geiss, L., & Engelgau, M. (2002). Trends 
in diabetes prevalence among American Indian and Alaska Native children, 
adolescents, and young adults. American Journal of Public Health, 92(9): 1485–
1490.  Retrieved from www.ncbi.nlm.nih.gov/pmc/articles/PMC1447266. 
Alaska Native Tribal Health Consortium Epidemiology Center (2015).  Aleutian and 
Pribilof’s Regional Health Profile.  Retrieved from 
http://www.anthctoday.org/epicenter/data/regions/ap/index.html 
American Diabetes Association. (2011). Diabetes statistics: Data from the 2011 National 
Diabetes Fact Sheet.  Retrieved from www.diabetes.org/diabetes-basics/diabetes-
statistics. 
Amparo P, Farr S., & Dietz, P. (2011). Chronic disease risk factors among American 
Indian/Alaska Native women of reproductive age. Public Health Research, 
Practice and Policy, 8(6), A118-1128  Retrieved from 
www.cdc.gov/pcd/issues/2011/nov/10_0268.htm 
Anderson, G. & Horvath, J. (2003). The growing burden of chronic disease in America.  
Public Health Reports, 119, 263-270.  Retrieved from 
www.ncbi.nlm.nih.gov/pmc/articles/PMC1497638/pdf/15158105.pdf 
Asch, S., Baker, D., Keesay, J., Broder, M., Schonalu, M., Rosen, M.,…Keeler, E. 
(2005). Does the collaborative model improve care for chronic heart failure?  
Medical Care, 43, 667-675.  Retrieved from www.randhealth.org. 
 
94 
 
Baker, D., Asch, S., Keesey, J., Brown, J., Chan, K., Joyce, G., Keeler, E. (2005). 
Differences in education, knowledge, self-management activities, and health 
outcomes for patients with heart failure care for under the chronic disease model: 
The improving chronic illness care evaluation. Journal of Cardiac Failure, 11, 
405-413.  Retrieved from 
www.sciencedirect.com/science/article/pii/S1071916405001375. 
Barron, R., Rimer, B., Coates, R., Kerner, J., Kaira, G., Melillo, S.,…Leeks, K. (2008) 
Client-directed interventions to increase community access to breast, cervical, and 
colorectal cancer screening: A systematic review. American Journal of Preventive 
Medicine, 35(1), Supplement: S56-S66.  doi:10.1016/j.amepre.2008.04.001 
Bell, W. (1983). Contemporary social welfare.  New York, NY: Macmillan. 
Berwick, D. (1989). Continuous improvement as an ideal in health care. The New 
England Journal of Medicine, 320(1), 53-56. 
Bertoia, M., Waring, M., Supta, P., Roberts, M., & Eaton, C.  (2012). Implications of new 
hypertension guidelines in the United States. Hypertension: Journal of the 
American Heart Association, 112, 639-644. doi: 
10.11161/HYPERTENSIONAHA.112.193714.   
Bodenheimer, T. (2003). Interventions to improve chronic illness care: Evaluating their 
effectiveness. Disease Management, 6(2), 63-71.  
doi:10.1089/109350703321908441 
 
95 
 
Bodenheimer, T., Chen, E., & Bennett, H. (2009). Confronting the growing burden of 
chronic disease: Can the U.S. health care workforce do the job? Health Affairs, 
28(1), 62-74.  doi:10.7326/0003-4819-142-10-200505170-00010 
Bogatz, G. & Ball, S. (1971). The second year of Sesame Street: A continuing evaluation. 
Princeton, NJ: Educational Testing Service.  Retrieved from 
files.eric.ed.gov/fulltext/ED122800.pdf. 
Bouchet, B, Francisco, M., & Ovret, J. (2002). The Zambia quality assurance program: 
successes and challenges. International Journal of Quality Health Care, 14, 
Supplement 1:89-95.  doi:10.1093/intqhc/14.suppl_1.89   
Blumentahal, D. (1996).  Quality of care: What is it?  New England Journal of Medicine.  
335:891-894. doi: 10.1056/NEJM199609193351213 
Bursell S., Cavallerano J., Cavallerano A., Clermont A., Birkmire-Peters D, Aiello L, 
Aliello, L. (2001) Stereo non-mydriatic digital-video color retinal imaging 
compared with early treatment diabetic retinopathy study seven standard field 35-
mm stereo color photos for determining level of diabetic retinopathy.  
Ophthalmology, 108(3):572–85.   doi:10.1016/S0161-6420(00)00604-7 
Burwick, D., Nolan, T.., & Whittington, J. (2008).  The triple aim: Care, health and cost.  
Health Affairs, 27(3):759-769).  Retrieved from 
http://content.healthaffairs.org/content/27/3/759.full  
Calhoun W., Ameredes, B., King, T., Icitovic, N., Bleecker, E., Castro,…& Boushey, H.  
(2012). Comparison of physician, biomarker, and symptom-based strategies for 
96 
 
adjustment of inhaled corticosteroid therapy in adults with asthma.  Journal of the 
American Medical Association, 308:987-997.  doi:10.1001/2012.jama.10893. 
Carey, R. & Lloyd, R.  (2001). Measuring quality improvement in health care: A guide to 
statistical process control applications.  Milwaukee, Wisconsin: American Society 
for Quality. 
Carroll, M., Cullen, T., Ferguson, S., Hogge, N., Horton, M., Kokesh, J.  (2011). 
Innovation in Indian Healthcare: Using health information technology to achieve 
health equity for American Indian and Alaska Native Populations.  Perspectives 
in Health Information Management, Winter 1(8):1-10.   Retrieved from 
www.ncbi.nlm.nih.gov/pmc/articles/PMC3035828/. 
Centers for Disease Control and Prevention. (1999). Framework for program evaluation 
in public health. MMWR, 48(No. RR-11).  Retrieved from 
stacks.cdc.gov/view/cdc/5204/. 
Centers for Disease Control and Prevention (2003). Health Status of American Indians 
compared with other racial/ethnic minority populations – selected states, 2001-
2002.  Morbidity and Mortality Weekly Report, 52(47):1148-52.  Retrieved from 
www.cdc.gov/mmwr/preview/mmwrhtml/mm5247a3.htm. 
Centers for Disease Control and Prevention. (2003). Diabetes prevalence among 
American Indians and Alaska Natives and the overall population–United States, 
1994–2002. Morbidity and Mortality Weekly Report, 52:702–704.  Retrieved from 
www.cdc.gov/mmwr/preview/mmwrhtml/mm5230a3.htm. 
97 
 
Centers for Disease Control and Prevention.(2008). National diabetes fact sheet, 2007. 
Atlanta, GA: U.S. Department of Health and Human Services; 2008. Retrieved 
from www.cdc.gov/Diabetes/pubs/factsheet07.htm  
Centers for Disease Control and Prevention. (2011). National diabetes fact sheet: 
National estimates and general information on diabetes and pre-diabetes in the 
United States, 2011. Atlanta, GA: U.S. Department of Health and Human 
Services, Centers for Disease Control and Prevention.  Retrieved from 
www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf. 
Centers for Disease Control and Prevention (2012). Chronic Diseases and Health 
Promotion.  Retrieved from: www.cdc.gov/chronicdisease/overview/index 
Centers for Disease Control and Prevention (2012).  Chronic Disease Overview.  
Retrieved from www.cdc.gov/chronicdisease/overview. 
Chassin, M. (1997).  Assessing strategies for quality improvement.  Health Affairs, 16(3), 
151-161.  doi: 10.1377/hlthaff.16.3.151 
Chen, H. (1996).  A comprehensive typology for program evaluation.  Evaluation 
Practice, 17(2): 121-130.  doi: 10.1177/109821409601700204. 
Chen, H. & Rossi, P. (1981).  Evaluating with sense: The theory-driven approach, 
Evaluation Review, 7: 283-302. 
Cheung, B., Ong, K., Cherry, S., Sham, P., Tso, A., & Lam K.  (2009). Diabetes 
prevalence and therapeutic target achievement in the United States, 1999-2006.  
American Journal of Medicine, 122(5), 443-453.  
DOI: http://dx.doi.org/10.1016/j.amjmed.2008.09.047 
98 
 
Chin, M., Drum, M., Guillen, M., Rimington, A., Levie, J., Krichhoff, A.,…& Schaefer, 
C. (2007).  Improving and sustaining diabetes care in community health centers 
with the health disparities collaboratives.  Medical Care, 45 (12): 1135-1143.  
Doi: 10.2337/diacare.27.1.2 
Clark, N., Brenner, J., Johnson, P., Peek, M., Spoonhunter, H., Walton, J.,…& Nelson, B.  
(2011). Reducing disparities in diabetes: The alliance model for health care 
improvements.  Diabetes Spectrum, 24(4), 226-230.  
doi:10.2337/diaspect.24.4.226 
Clarke, A.  (1999). Evaluation, research: An introduction to principles, methods and 
practice.  Thousand Oaks, CA: Sage.   
Cohen, D., McDaniel, R., Crabtree, B., Ruhe, M., Weyer, S., Tallia, A.,…&.Stange, K. 
(2004).  A practice change model for quality improvement in primary care 
practice.  Journal of Healthcare Management, 49(3): 155-170.   
Coleman, K., Austin, B., Brach, C., & Wagner, E. (2009).  Evidence on the Chronic Care 
Model in the new millennium.  Health Affairs, 28(1): 75-85.  
doi: 10.1377/hlthaff.28.1.75 
Coulter, A. (1991).  Evaluating the outcomes of health care.  In J. Gabe, M. Calnan, & M. 
Bury (Eds.). The sociology of the health service (pp. 115-139).  London: 
Routledge. 
Cretin, Shortell, Keeler (2004).  An evaluation of collaborative interventions to improve 
chronic illness care: Framework and study design.  Evaluation Review, 28(1) 28-
50.  doi:10.1177/0193841X3256298 
99 
 
Damin, S. Baillie, R., Cunningham, J., Robinson, G., Dowden, M., Stewart, A.,…& 
Weeramanthri, T. (2008).  Describing and analyzing primary health care system 
support for chronic illness care in Indigenous communities in Australia's Northern 
Territory – use of the Chronic Care Model.  BMC Health Services Research, 
8:112.  doi: 10.1186/1472-6963-8-112 
Daniel, D., Norman, J., Davis, C., Lee, H., Hindmarsh, M., McCulloch, D.,…& 
Sugarman, J.  (2004). A state-level application of the chronic illness breakthrough 
series: Results from two collaboratives on diabetes in Washington State.  Joint 
Commission Journal on Quality and Safety, 30(92): 69-79.  Retrieved from 
http://www.researchgate.net/publication/7613332_A_state-
level_application_of_the_chronic_illness_breakthrough_series_results_from_two
_collaboratives_on_diabetes_in_Washington_State. 
Daponte, B. (2008).  Evaluation essentials: Methods for conducting sound research.  San 
Francisco, CA: Jossey-Boss. 
Davis, D., Thomson, M., Oxman, A., & Haynes, R.  (1995). Changing physician 
performance: A systematic review of the effect of continuing medical education 
strategies.  Journal of the American Medical Association., 272: 797-802.  
Retrieved from 
www.researchgate.net/publication/15547979_Changing_Physician_Performance_
A_Systematic_Review_of_the_Effect_of_Continuing_Medical_Education_Strate
gies 
 
100 
 
Davidson, E. (2005).  Evaluation methodology basics: The nuts and bolts of sound 
evaluation.  Thousand Oaks, CA: Sage. 
Deming, W. (1986).  Out of the Crisis, Cambridge, MA: MIT Press.   
Devol, R. & Bedroussian, A. (2007).  An unhealthy America: The economic burden of 
chronic disease, charting new course to save lives and increase productivity and 
economic growth.  Executive summary and research findings by the Milken 
Institute, October 2007.  Retrieved from 
http://www.sophe.org/Sophe/PDF/chronic_disease_report.pdf 
Doescher, M., and Jackson, E.  (2009). Trends in cervical and breast cancer screening 
practices among women in rural and urban areas of the United States.  Journal of 
Public Health Management Practice, 15(3): 200-209.  doi: 
10.1097/PHH.0b013e3181a117da. 
Donobedian, A. (1966).  Evaluating the quality of medical care.  Millbank Memorial 
Fund Quarterly, 44:166-206. 
Duckers M., Wagner C., Groenewegen P. (2008) Developing and testing an instrument to 
measure the presence of conditions for successful implementation of quality 
improvement collaboratives. BMC Health Services Research. 8:172  doi: 
10.3109/13561820.2013.874981 
Dwight-Johnson, Eli, K., & Lee, P. (2005).  Can collaborative care address the needs of 
low-income Latinas with comorbid depression and cancer?  Results from a 
randomized pilot study.  Psychosomatics, 46: 224-232. 
doi: 10.1176/appi.psy.46.3.224 
101 
 
Egan, B., Zhao, Y., & Axon, R.  (2010). U.S. trends in prevalence, awareness, treatment, 
and control of hypertension, 1988-2008.  Journal of the American Medical 
Association, 303(20), 2043-2050. doi:10.1001/jama.2010.650 
Ferlie, E. & Shortell, S. (2001).  Improving the quality of health care in the United 
Kingdom and the United States: A framework for change.  The Milbank 
Quarterly, 79(2), 283-415.  doi:10.1108/JHOM-01-2013-0001 
Fitzpatrick, J., Sanders, J., & Worthen, B.  (2011). Program evaluation: Alternative 
approaches and practical guidelines.  Boston, MA:Pearson  
Fleming, B. Greenfield, S., Engelgau., M., Pogach, L., Clauser, S., & Parrot, M. (2001).  
The Diabetes Quality Improvement Project: moving science into health policy to 
gain an edge on the diabetes epidemic.  Diabetes Care, 24: 1815-1820.  doi: 
10.2337/diacare.24.10.1815 
Ford, E., Li, C., Person, W., Shao, G., & Mokdad, A.  (2010). Trends in 
hypercholesterolemia, treatment and control among United States adults.  
International Journal of Cardiology, 40(2), 226-235.  doi: 
doi:10.1016/j.ijcard.2008.11.033 
Fortuine, R. (1986).  Alaska Native Medical Center: A history 1953-1983.  Anchorage, 
AK: Terragraphica. 
Gilbody, S., Bower, P., Fletcher, J., Richards, D., & Sutton, A. (2006).  Collaborative 
care for depression: A cumulative meta-analysis and review of longer-term 
outcomes.  Archives of Internal Medicine, 166: 2314-2321.  
doi:10.1001/archinte.166.21.2314. 
102 
 
Glasgow, R., Funnell, M., Bonomi, A., Davis, C., Beckham, V., & Wagner, E.  (2002). 
Self-management aspects of the improving chronic illness care breakthrough 
series: Implementation with diabetes and heart failure teams.  Annals of 
Behavioral Medicine, 24(2): 80-87.  doi: 10.1207/S15324796ABM2402_04 
Glasgow, R., Orleans, T., and Wagner, Curry, S., and Solberg, L. (2001).  Does the 
Chronic Care Model serve also as a template for improving prevention?  The 
Milbank Quarterly, 79(4): 579-612.  doi: 10.1111/1468-0009.00222 
Goetzel, R., Long, S., Ozminkowski, R., Hawkins, K., Wang, S., & Lynch, W. (2004).  
Health Absence disability and presenteeism cost estimates of certain physical and 
mental health conditions affecting U.S. employers.  Journal of Occupational and 
Environmental Medicine, 46(4), 398-412.  doi: 
10.1097/01.jom.0000121151.40413.bd 
Goran, M., Roberts, J., & Rodak, J. (1976).  Regulating the quality of hospital care: An 
analysis of the issues pertinent to national health insurance.  In R.H. Egdahl & 
P.M. Gortman (Eds).  Quality assurance in health care. (pp,. 61-87).  
Germantown, MD: Aspen Systems Corporation. 
Grossman E., Keegan T., Lessler A, Huong, M., Huynh, L., O’Malley, J., Guadagnoli, E. 
,& Landon, B.. Inside the health disparities collaborative: A detailed exploration 
of quality improvement at community health centers, Medical Care. 2008;46:489-
496.  doi: 10.1097/MLR.0b013e31815f536 
103 
 
Guba, Y. & Lincoln, E. (181).  Effective evaluation: Improving the usefulness of 
evaluation.  Results through responsive and naturalistic approaches.  San 
Francisco: Jossey-Bass. 
Gupta, S., Tong, L., Allison, J., Carter, E., Koch, M., Rockey, D.,…& Skinner, C.  (2009) 
Screening for colorectal cancer in a safety-net health care system: Access to care 
is critical and has implications for screening policy.  Cancer, Epidemiology, 
Biomarkers and Prevention, 18(9): 2372-2379.  doi: 10.1158/1055-9965.EPI-09-
034. 
Halladay, J., DeWalt, D., Wise, A, Qaqish, B., Reiter, K., Lee, S.,…& Donahue, K. 
(2014).  More extensive implementation of the Chronic Care Model is associated 
with better lipid control in diabetes.  Journal of the American Board of Family 
Medicine, 27(1): 34-41.  doi: 10.3122/jabfm.2014.01.130070. 
Hroscikoski, M., Solberk, L., Sperl-Hillen, J., Harper, P., McGrail, M., & Crabtree, B.  
(2006). Challenges of change a qualitative study of chronic care model 
implementation.  Annals of Family Medicine, 4(4): 317-326.  doi: 
10.1370/afm.570 
Homer, C., Forbes, P., Horvitz, L., Peterson, E., Wypij, D., & Heinrich, P. (2005).  
Impact of a quality improvement program on care and outcomes for children with 
asthma.  Archives of Pediatric and Adolescent Medicine, 159:464-469.  
doi:10.1001/archpedi.159.5.464 
Hung, D. & Shelley, D.  (2009). Impacting Treatment use and costs: Multilevel analysis 
of the chronic care model and 5A services for treating tobacco use in urban 
104 
 
primary care clinics.  Health Services Research, 44:103-127.  doi: 
10.1111/j.1475-6773.2008.00944.x 
Indian Health Service, Alaska Area. (2013). Alaska 2012 and 2013 IHS Active user 
population report.   
Indian Health Service (no date) The Chronic Care Model for the Indian Health Service.  
Retrieved from www.ihs.gov/ipc/index.cfm?module=dsp_ipc_models_caremodel 
Indian Health Service, (2013).  Indian Health Service: Indian Health Disparities.  
Retrieved from www.ihs.gov/newsroom/factsheets/disparities/. 
Indian Health Service, (2013).  IHS Diabetes care and outcomes audit.  Retrieved from 
www.ihs.gov/newsroom/factsheets/diabetes. 
Indian Health Service, (2011) “Heart Disease & Strokes.”  IHS Health and Heritage 
Brochure- Health Disparities, available at www.ihs.gov. 
Indian Health Service, (2011), Improving patient care: Improving the quality and access 
to care.  Evaluation.  Retrieved from 
www.ihs.gov/ipc/index.cfm?module=dsp_ipc_resources_eval. 
Indian Health Service (2014).  Improving Patient Care Resource Guide.  Retrieved from 
http://www.ihs.gov/ipc/documents/ResourceGuide_IPC5_January2014.pdf 
Indian Health Service.  (2007). Special Diabetes Program for Indians, 2007 Report to 
Congress: on the Path to a Healthier Future.  Bethesda, MD: US Dept of Health 
and Human Services, Indian Health Service.   
105 
 
Indian Health Service (2013).  “Where are we now?”  Opening remarks by Dr. Yvette 
Roubideaux, Director of the Indian Health Service, given at the Quality and 
Innovation Virtual Session May 29, 2013.  
Institute for Health Care Improvement (2012).  History.  Retrieved from 
www.ihi.org/about/Pages/History.aspx. 
Institute of Medicine (2000).  To err is human: Building a safer health system.  
Washington, DC: National Academy Press.  Retrieved from 
http://iom.nationalacademies.org/~/media/Files/Report%20Files/1999/To-Err-is-
Human/To%20Err%20is%20Human%201999%20%20report%20brief.pdf 
Institute of Medicine (2001).  Crossing the quality chasm: a new health system for the 
21st century.  Washington DC. 
Johnson, J., AlSayah, F., Wozniak, L., Rees, S., Suprovich, A., Chik, C.,…& Majumdar, 
S.  (2012). Controlled trial of a collaborative primary care team model for patients 
with diabetes and depression: Rationale and design for a comprehensive 
evaluation.  BMC Health Services Research, 12: 258-277.  doi:10.1186/1472-
6963-10-49 
Kern, L., Barron, Yolanda, Dhopeshwarkar, R, Edwards, A., & Kaushai, R.  (2011) 
Electronic Health Records and Ambulatory Quality of Care.  Journal of General 
Internal Medicine, 28(4): 496-503.  doi: 10.1007/s11606-012-2237-8 
Kilo, C. (1998).  A framework for collaborative improvement: Lessons from the institute 
for healthcare improvement’s breakthrough series.  Quality Management in 
Health Care, 8(4), 1-13.  doi:10.1016/j.childyouth.2015.06.00 
106 
 
Kim, C. (2000).  Recruitment and retention in the Navajo Area Indian Health Service.  
Western Journal of Medicine, 173: 240-243.  Retrieved from 
www.ncbi.nlm.nih.gov/pmc/articles/PMC1071101/pdf/wjm17300240.pdf 
Knight,  A., Ford, D., Audehm, R., Colagiuri, S. and Best, J. (2012).  The Australian 
Primary Care Collaboratives Program: improving diabetes care.  BMJ Quality and Safety, 
21: 956-963.  doi:10.1136/bmjqs-2011-000460 
Koffman, D., Granade, S., & Arwun, V. (2008).  Strategies for establishing policy, 
environmental and systems-level Interventions for managing high blood pressure 
and high cholesterol in health care settings: A qualitative case study.  Public 
Health Research, Practice and Policy, 5(3), 1-16.  doi: 10.1186/1471-2458-12-
1037. 
Landon B., LeRoi, S., Hicks, L., O'Malley, A., Lieu, T., Keegan, T.,…& Guadagnoli, E. 
(2007). Improving the management of chronic disease at community health 
centers. New England Journal of Medicine, 2007;356:921-934. doi: 
10.1056/NEJMsa062860 . 
Langley, G., Moen, R., Nolan, K., Nolan, T., Norman, C., & Provost, L.  (2009)  The 
Improvement guide: A practical approach to enhancing organizational 
performance. Second Ed.  San Francisco, CA: Jossey-Bass, 
Leape, L., Kabcenell, A., Gandhi, T., Carver, P., Nolan, T., & Berwick, D., (2000).  
Reducing adverse drug events: Lessons from a breakthrough series collaborative.  
107 
 
Joint Commission Journal of Quality Improvement and Patient Safety, 26:321-
331.  doi:10.1111/j.1475-6773.2010.01102.x. 
Mangione-Smith, R., Schonian, M., Chan, K., Keesey, J., Rosen, M., Louis, T., & Keeler, 
E.  (2005)  Measuring the effectiveness of a collaborative for quality 
improvement in pediatric asthma care: Does implementing the Chronic Care 
Model improve processes and outcomes of care?  Ambulatory Pediatrics, 5:75-82.  
doi:10.1186/1471-2318-13-62 
Mark, M., Henry, G., & Julnes, G. (2000).  Evaluation: An integrated framework for 
understanding guiding and improving policies and programs.  San Francisco, CA. 
Matthias, S., Mangione-Smith, R., Chan, K., Keesey, J., Rosen, M., Louis, T.,…& 
Keeler, E.  (2005). Evaluation of a quality improvement collaborative in asthma 
care: Does it improve processes and outcomes of care?  Annals of Family 
Medicine, 3(3): 200-208.  doi: 10.1370/afm.269 
Martinson, R. (1974).  What works?  Questions and answers about prison reform.  Public 
Interest, 35: 22-45. 
McGlynn, E., Asch, S., Adams, J., Keesey, J., Hicks, J., DeCristofaro, A., & Kerr, A. 
(2003).  The quality of health care delivered to adults in the United States.  New 
England Journal of Medicine, 348: 2635-2645.  doi: 10.1056/NEJMsa022615 
Mensah, G. & Brown, D. (2007).  An overview of cardiovascular disease burden in the 
United States.  Health Affairs, 26: 38-48.  doi: 10.1377/hlthaff.26.1.38 
108 
 
Minkman, M., Ahaus, L., & Houjsman, R., (2007) Performance improvement based in 
integrated quality management models: What evidence do we have?  A systematic 
literature review.  International Journal for Quality in Health Care, 19: 90-104.  
doi: http://dx.doi.org/10.1093/intqhc/mzl071 90-104 
Mohler, P., & Mohler, N.  (2005). Improving chronic illness care: Lessons learned in a 
private practice.  Family Practice Management, November/December: 50-56. 
Mokdad, A., Marks, J., Stroup, D., & Gerberding, J. (2004). Actual causes of death in the 
United States, 2000. Journal of the American Medical Association, 10:1238–
1245.  doi:10.1001/jama.291.10.1238 
Morikawa, T., Kato, J., Yamaji, Y., Wade, R., Misushima, T. and Shiratori, Y.  (2005).  
A comparison of the Immunochemical fecal occult blood test and total 
colonoscopy in the symptomatic population.  Gastroenterology, 129(2): 422-428.  
doi:10.1053/j.gastro.2005.05.056. 
Nadeem, E, Olin, S., Hill, L., Hoagwood, K., Horwitz, S.  (2013). Understanding the 
components of quality improvement collaboratives: A systematic literature 
review.  The Milbank Quarterly, 91(2): 354-394.  doi: 10.1111/milq.12016. 
National Heart, Lung, and Blood Institute. (2004). Morbidity and mortality: 2004 
Cardiovascular, Lung, and Blood Diseases.  Bethesda, MD.   
National Park Service, no date.  Aleutian World War II: Dutch Harbor bombing, June 
1942.  Retrieved from www.nps.gov/aleu/historyculture/raid-dutch-harbor.htm 
109 
 
Naylor, J., Schraer, C., Mayer, A., Lanier, A., Treat, C., & Murphy, N.  (2003). Diabetes 
among Alaska Natives: A review.  International Journal of Circumpolar Health, 
Dec, 62(4):363-87. 
Nolan, K., Schall, M., Fabian, E., & Nolan, T.  (2006).   Using a framework for spread: 
The case of patient access in the Veterans Health Administration.  Journal of 
Quality and Patient Safety, 31(5): 339-347. 
O’Connell, J., Wilson, C., Manson, S., & Acton, K.  (2012). The costs of treating 
American Indian adults with diabetes within the Indian Health Service.  Research 
and Practice, 102(2): 301-308.  doi: 10.2105/AJPH.2011.300332 
O’Leary, B., Olynyk, J., Neville, A., and Platell, C.  Cost-Effectiveness of Colorectal 
Cancer Screening: Comparison of community-based flexible sigmoidoscopy with 
fecal occult blood testing and colonoscopy.  Journal of Gastroenterology and 
Hematology, 19(1):38-47.  doi: 10.1111/j.1440-1746.2004.03177.x 
Office of the General Counsel, Commission on Civil Rights (2004).  Native American 
health care disparities briefing: Executive summary.  Retrieved from 
www.hss.state.ak.us/commissioner/tribalhealth/docs/Native_American_Health_C
are_Disparities.pdf.   
Ouwens, M., Wollersheim, H., Hermens, R., Hulscher, M., & Grol, R. (2005).  Integrated 
care programmes for chronically ill patients: a review of systematic reviews.  
International Journal of Quality Health Care, 17(2): 141-6.  
doi: http://dx.doi.org/10.1093/intqhc/mzi016 
 
110 
 
Paquette-Warren, Roberts, Fourmie, Tyler, Brown, & Stewart. (2014). Improving chronic 
care through continuing education of interprofessional primary healthcare teams: 
a process evaluation.  Journal of Interprofessional Care, May, 28(3):232-238.  doi: 
10.3109/13561820.2013.874981.   
Patton, M. (1980).  Practical evaluation.  Beverly Hills, CA: Sage 
Patton, M. (2008).  Utilization-focused evaluation (4th ed).  Thousand Oaks, CA: Sage 
Pawson, R. & Tilley, N.  (2011). Realistic evaluation.  Los Angeles, CA: Sage 
Pearson, Wu, Schaefer, Bonomi, Shortell, Mendel,…& Keeler (2006).   Assessing the 
implementation of the chronic care model in quality improvement collaboratives.  
HSR: Health Services Research, 40:4: 978-996  
doi: 10.1111/j.1475-6773.2005.00397.x 
Polacsek, M., Orr, L., Letourneau, L., Rogers, V., Holmberg, R., O’Rourke, K.,…& 
Gortmaker, S. (2009)  Impact of a primary care intervention on physician practice 
and patient and family behavior: Keep ME Healthy – The Main Youth 
Overweight Collaborative.  Pediatrics, 123 (suppl. 5):S258-66. Doi: 
10.1542/peds.2008-2780C 
Posevac, E. & Carey, R. (1997).  Program evaluation: Methods and case studies (5th Ed).  
Upper Saddle River, NJ: Prentice Hall. 
Preskill, H. & Torres, R. (1998).  Evaluative inquiry for learning in organizations.  
Thousand Oaks, CA: Sage 
Provist, L. & Murray, S. (2011).  The health care data guide: Learning from data for 
improvement.  San Francisco, CA: Josey-Bass. 
111 
 
Reid, R., Coleman, K., Johnson, E., Fishman, E., Hsu, C., Soman, M.,…& Larson, E. 
(2010).  The Group Health medical home at year 2: Cost savings, higher patient 
satisfaction, and less burnout for providers.  Health Affairs, 28(5): 835-843.  
doi: 10.1377/hlthaff.2010.0158 
Rosenqvist, U., Carlson, A., & Luft, R. (1988).  Evaluation of a comprehensive program 
for diabetes care at the primary health care level.  Diabetes Care, 11:269-274.  
doi: 10.2337/diacare.11.3.269 
Ross, R. & Gendreau, P. (1980).  Effective correctional treatment.  Toronto: 
Butterworths. 
Rossi, P. & Freeman, H. (1993).  Evaluation: A systematic spproach, 5th edition, 
Newbury Park, CA: Sage 
Rossi, P., Lipsey, W., & Freeman, H. (2004).  Evaluation: A systematic approach, 7th 
edition, Thousand Oaks, CA:Sage   
Roubideaux, Y. (2011, April).  Improvements in Indian Care.  A seminar presented at the 
Improving Patient Care 3 Collaborative in Denver, Colorado. 
Schonlau, M., Mangione-Smith, R., Chan, K., Keesay, J., Rosen, M., Louis, T.,…& 
Keeler, E.  (2005). Evaluation of a quality improvement collaborative in asthma 
care: Does it improve processes and outcomes of care?  Annals of Family 
Medicine, 3(3):200-208).  doi: 10.1370/afm.269 
Schulz, L., Bennett, P., Ravussin, E., Kidd, J., Kidd, K., Esparaza, J., & Valencia, M. 
(2006). Effects of traditional and western environments on prevalence of type 2 
112 
 
diabetes in Pima Indians in Mexico and the U.S.  Diabetes Care, 29(8): 1866-71.  
doi: 10.2337/dc06-0138 
Scrivner, M.  (1967). The methodology of evaluation in R.W. Tyler, R. M. Gagne and M. 
Scriven (eds) Perspectives of Curriculum Evaluation, Chicago, IL: Rand 
McNally.  
Sequist,T.,  Cullen, T., Bernard, K., Shaykevich, S., Oray, J., & Ayanian, J.  (2010). 
Trends in quality of care and barriers to improvements in the Indian Health 
Service.  Journal of General Internal Medicine, 26(5):480–6.  doi: 
10.1007/s11606-010-1594-4.   
Shadish, W. Cook, T., & Leviton, L.  (1991). Foundations of Program Evaluation.  
Beverly Hills, CA: Sage. 
Shah, M. & Layman, E. (2005).  Using a multipronged approach to implement 
organizational performance improvement.  The Health Care Manager, 24(1), 42-
54.  doi: 10.1097/00126450-200501000-00008 
Shaw, E., Chase, S., Howard, J., Nujtting, P., Crabtree, B.  (2012). More black box to 
explore: How quality improvement collaboratives shape practice change.  Journal 
of the American Board of Family Medicine, 25(2): 149-157.  
doi:10.3122/jabfm.2012.02.110090 
Shortell, S., Bennett, C., & Byck, G. (1998).  Assessing the impact of continuous quality 
improvement on clinical practice: What will it take to accelerate the progress?  
Milbank Quarterly, 76:593-634.  doi: 10.1111/1468-0009.00107 
113 
 
Shortell, S., Marstellar, & Lin, M. (2004).  The role of perceived team effectiveness in 
improving chronic illness care.  Medical Care, 42:1040-1048.   
Shultz et al. (2006).  Effects of traditional and western environments on prevalence of 
type 2 diabetes in Pima Indians in Mexico and the U.S.  Diabetes Care, 
29(4):1866-1871.  doi: 10.2337/dc06-0138 
Sifrim, Z., Barker, P., & Mate, K.  (2012) What gets published: The characteristics of 
quality improvement research articles from low and middle-income countries.  
BMJ Quality and Safety, 21(55):423-31.  Retrieved from 
http://qualitysafety.bmj.com/content/21/1.toc.   
Solberg, L., Asche, S., Pawlson, L., Scholle, S., & Shih, S. (2008).  Practice systems are 
associated with high-quality care for diabetes.  The American Journal of Managed 
Care, 14(2), 85-92.  Retrieved from 
http://www.internetgroup.ca/clientnet_new/docs/High%20Quality%20Care%20fo
r%20Diabetes.pdf 
Spere-Hillen, J., O’Connor, P., Carlson, R., Lawson, T., Halstenson, C., Crowson, T., & 
Wuorenma, J.  (2000). Improving diabetes care in a large health care system: An 
enhanced primary care approach.  Journal of Quality Improvement, 20(10).  615-
622. 
State of Alaska, Department of Labor and Workforce Development.  2010.  Demographic 
data for Atka, Nikolski and Unalaska/Dutch Harbor.  Retrieved from 
live.laborstats.alaska.gov/cen/dparea.cfm 
 
114 
 
Stiles, R. & Mick, S. (1994).  Classifying quality initiatives: A conceptual paradigm for 
literature review and policy analysis.  Hospital and Health Services, 39(3), 209-
326. 
Swarz, D., Schwarz, R., Gauchan B, Andrews, J., Sharma, R., Karelas, G.,…& Smith-
Rohrberg, M.  (2011). Implementing a systems-oriented morbidity and mortality 
conference in remote rural Nepal for quality improvement.  BMJ Quality and 
Safety, 20(12):1082-1088.  doi:10.1136/bmjqs-2011-000273 
Streiner, D. & Norman, G. (1995).  Health measurement scales: A practical guide to 
their development and use, 2nd edition, New York, NY: Oxford University Press. 
Thorndike, A., Rigotti, N., Stafford, R. & Singer, D. (1998).  National Patterns in the 
Treatment of Smokers by Physicians.  Journal of the American Medical 
Association, 279(8): 604-608.  doi:10.1001/jama.279.8.604. 
Tsai, A., Morton, S., Mangione, C. & Keeler, E. (2011).  A meta-analysis of interventions 
to improve care for chronic illness.  American Journal of Managed Care, 11(8): 
478-488.  Retrieved from http://www.ajmc.com/journals/issue/2005/2005-08-
vol11-n8/Aug05-2103p478-488/ 
U.S. Department of Health and Human Services. (2009). National healthcare quality 
report 2008.  (AHRQ Publication No. 09-10001). Rockville, MD. 
Wagner, E. Austin, B, & Von Korff, M., (1996).  Organizing care for patients with 
chronic illness.  Milbank Quarterly, 74(4), 511-544.  doi: 10.2307/3350391 
115 
 
Wagner, E., Austin, B., Davis, C., Hindmarsh, M., Schaefer, J., & Bonami, A. (2001).  
Improving Chronic Illness Care: Translating Evidence into Action.  Health 
Affairs. 20(6):64-78.  doi: 10.1377/hlthaff.20.6.64 
Wagner, E.  (1998). Chronic disease management: What will it take to improve care for 
Chronic Illness?  Effective Clinical Practice, 1(1):2-4.  Figure of chronic care 
model republished with permission of  the American College of Physicians 
Wang, A., Wolf, M., Carlyle, R., Wilkerson, J., Porterfield, D., & Reaves, J. (2004).  The 
North Carolina experience with diabetes health disparities collaboratives.  Joint 
Commission Journal on Quality and Safety, 30(7): 396-404. 
Ward, B., Shiller, J., & Goodman, A.  Multiple Chronic Conditions Among US Adults: A 
2012 Update.  (2014). Prevention of Chronic Disease, April (11):130389-91.  
Retrieved from doi: http://dx.doi.org/10.5888/pcd11.130389 . 
Watson, D., Broemeling, A., & Wong, S. (2009).   Results-based logic model for primary 
healthcare: A conceptual foundation for population-based information systems.   
Health Policy. November; 5(Spec No): 33–46.  Retrieved from 
www.researchgate.net/profile/Sabrina_Wong/publication/47636588_A_results-
based_logic_model_for_primary_healthcare_a_conceptual_foundation_for_popul
ation-based_information_systems/links/02e7e52141b83515ad000000.pdf 
Williams, S. & Torrens, P. (Eds).  (2002). Introduction to health services.  Albany, NY: 
Delmar. 
116 
 
Wilson, T., Berwick, D., & Cleary, P. (2009).  What do collaborative improvement 
projects do? Experience from seven countries. Medical Care, 47(9): 1026-1030. 
Retrieved from http://www.fachc.org/pdf/WhatDoCollaborativesDo.pdf 
  
117 
 
Appendix A: Letter of Permission to Use Wagner’s Chronic Care Model 
 
 
ROECP1217560 
March 1, 2014 
 
Oonalaska Wellness Center  
PO Box 1130 Unalaska,  
Alaska 99685  
 
Dear Ms. Siemens: 
 
Thank you for your request for print format of the following from Effective Clinical Practice: 
 
Figure 1: Edward H. Wagner, MD, MPH, Chronic Disease Management: What 
Will It Take To Improve Care for Chronic Illness? Effective Clinical Practice, 
Aug/Sept 1998, Vol 1 
 
Permission is granted to republish the preceding material with the understanding that you will 
give appropriate credit to Effective Clinical Practice as the original source of the material. Any 
translated version must carry a disclaimer stating that the American College of Physicians 
is not responsible for the accuracy of the translation. This permission grants non-exclusive, 
worldwide rights for this edition / volume in print format only.  ACP does not grant permission to 
reproduce entire articles or chapters on the Internet. This letter represents the agreement between 
ACP and Annette Siemens FNP, BSN, MSN, MPH 
for request ROECP1217560 and supersedes all prior terms from the requestor. 
 
Thank you for your interest in Effective Clinical Practice. If you have any further questions or 
would like to discuss the matter further, please contact me at 856-489-8555 or fax 856-489-4999. 
 
Sincerely, 
 
Gina Brown 
Permissions Coordinator 
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Appendix B: Definitions 
Action Period: The time between learning sessions when teams work in their home 
organizations on improving their processes.   
 
Action Period Calls: Calls are scheduled every other week thru the length of the 
collaborative.  The calls are designed to encourage participation from sites.  Content is 
provided and teams share ideas, tools and successes and challenges.  
 
Action Plan: These are work plans prepared by participation teams that help to guide 
tests for change, implementation and spread. 
 
Advanced Access: A system designed in such a way that patients can received the care 
they want when and how they want it. 
 
Annotated Run Chart: A line chart that shows results of improvement efforts plotted 
over time.  The changes made are noted on the line chart allowing the viewer to connect 
results with system changes. 
 
Chronic Disease: a condition that is ongoing (a year or more), requires continued 
medical care and/or limits in some way activities of daily living.   
 
Clinical Information System (CIS): This is an integrated, comprehensive patient 
centered information system.  The Patient and Registration Management System (RPMS) 
is an example of a CIS. 
 
Community Health Aide/Practitioner: Alaska Tribal Health System specific provider 
that is trained to provide direct health care in villages across Alaska. 
 
Cycle Time: The amount of time that a patient spends at a clinic visit.  The cycle time is 
used to identify areas of backlog that can be improved. 
 
Decision Support (DS): A variety of methods to assist patients and providers to make 
informed choices about care. 
 
Delivery System Design (DSD): Provision of patient care including the roles of the 
members of the health care teams, types of appointments and follow-up techniques used 
by the clinic.   
 
Electronic Health Record (EHR): The patient’s medical record in electronic form.  It 
provides a variety of functions for data retrieval to support patient review at each 
encounter and for follow-up. 
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Government Performance and Results Acts (GPRA): Federally mandated 
performance indicators with annual goals to measure Indian Health Service (IHS) 
progress in improving the health status of American Indians and Alaska Natives. 
 
Micro system: A smaller portion of the entire organization (e.g., one clinic or one 
provider in a clinic).   
 
Virtual Learning Session: Training events of the IPC Collaborative.  The virtual 
learning session are designed for participants to gather new knowledge on presented IPC 
subject matter, share experiences, and develop strategies to overcome barriers to patient 
care improvement. 
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Appendix C: Indian Health Service Improving Patient Collaborative Background 
and Process 
The clinic’s overseeing health department began its discussion regarding quality 
health care in 2009.  Several members of the health department attended the Institute for 
Health Care Improvement conference, which sparked even more interest in the process of 
improving patient care.  At that time the organization became aware of the Indian Health 
Service IPC program.  The agency applied to participate in the collaborative and was 
selected to start the IPC 3 program in the fall of 2011.   
The first task as part of IPC was to complete the pre-work assignments, to be 
completed prior to attending the first Learning Session.  The pre-work laid the foundation 
for successful improvement activities during the IPC Collaborative.  The first pre-work 
assignment was to identify and choose members of the improvement team.  The team 
should consist of at least one provider, one member of leadership, support staff, and at 
least one community member.  The names were then uploaded to the IPC Knowledge 
Portal.   
The Knowledge Portal (KP) is a secure site that requires registration from IPC 
members. The KP stores team documents, session information and documents for 
viewing and review.  Individuals have to register and receive a user name and password 
to access the site.  Other pre-work assignments included assessing clinic capabilities in 
terms of patient centered care.  This assignment included the primary care profile, 
assessing the practice through the eyes of the patient, a primary care practice activity 
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survey, 5 patient care cycle times and developing a story board, outlining current 
practices of patient care at the clinic.   
Members of the core IPC team attended in-person learning sessions in Denver and 
Phoenix.  The last learning session was virtual with three days of on-line Adobe Connect 
meetings with a presentation of a variety of IPC topics.  During each learning session, the 
UWC team members participated in team meetings to work on goals, solving problems 
and discussing issues with the IPC National staff.   
Time was also set aside during the face-to-face meetings to learn from other IPC 3 
teams during poster sessions or networking time during breaks.  Each learning session 
had multiple learning choices depending on the role of the team member, including 
sessions for providers, sessions for IT personnel, and sessions for managers and 
leadership.  At each learning session a plenary reviewed IPC principles and the core 
concepts of patient-centered care.  
At each learning session, times were available for the various participating teams 
to meet to work on assignments given at the learning sessions.  For example, at learning 
Session I the teams were to develop an aim statement.  The aim statement is a measurable 
and time-sensitive document, outlining what the team expects will happen as a result of 
the implemented improvement process.  As the team worked on their assignments, 
experts from the national IPC team rotated among the team tables to provide input and 
suggestions on assignment’s development.   
Upon return to their home clinic, the teams participated in IPC Action Calls every 
other week.  During these calls, teams hear about an IPC topic with the remainder of the 
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time spent on presentations from one or two participating teams on how they have 
implemented some aspect of the IPC.  At the end of the call, the national IPC team is 
available to answer questions.    Teams receive assignments with information on how to 
submit required data and narrative reports monthly.  Selected data sets and a narrative 
report monthly are uploaded to the IPC site, www.improvingindianhealth.org.  Reports 
and data are available for viewing by registered IPC participants.   
The learning sessions build upon each other and the teams are expected to 
progress in their knowledge of IPC and the ability to apply its principles.  Learning 
Sessions build on information learned during the pre-work done by the teams.     
IPC provided an examination of changes in the following areas: leadership, 
community involvement, patient and the family, identification of the microsystem, 
completion and refinement, definition of the improvement team, development and 
optimization of the care team, communication with staff, patients and the community and 
access and continuity. 
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Appendix D: Collaborative Monthly Data Collection Table 
IPC data collection sheet. 
Data to be Collected Process or  
Outcome Measure 
Goal 
% of patients with BMI measured Process 80% 
% of patients with tobacco screen Process 80% 
% of patients with domestic violence screen Process 80% 
% of patients with BP Screen Process 80% 
Percent of patients with depression screen Process 80% 
Percent of patients with colorectal cancer screen Process 70% 
Percent of patients with breast cancer screen Process 70% 
Percent of patients with cervical cancer screen in 
last three years 
Outcome 70% 
Percent of patients who smoke  Process 40% 
Percent of smokers with cessation visit in last 
two years 
Process 70% 
Percent of CVD patients with controlled lipids Outcome 70% 
Percent of DM patients with controlled HgbA1c Outcome 70% 
Percent of HTN pts with controlled BP Outcome 70% 
Staff satisfaction survey Outcome Monthly 
Visit cycle time Process 45 min 
Patient Satisfaction Outcome Rating of 6 
or higher 
Percent of patients empaneled to a primary care 
provider 
Outcome 90% 
Continuity of care to a primary care provider Process 80% 
Third next available appointment to a medical 
provider 
Outcome 0 days 
PDSA Cycles 
 
Process 5 per 
participant 
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Appendix E: Intake Screening Form 
Intake Screen Form 
 
Patient Name: ____________________  MR#:____________  Date:_________ 
 
Alcohol Screen/CAGE 
 
Do you ever feel like you should cut down on your drinking?                            Y N 
Do people annoy you by criticizing your drinking?                 Y N 
Do you ever feel bad or guilty about your drinking?                                            Y N 
Do you ever have a drink first thing in the morning to steady your nerves or 
get rid of a hangover? 
Y N 
 
Depression Screen 
 
Over the past 2 weeks have you felt down, depressed or hopeless?                     Y N 
Do you ever feel little interest or pleasure in doing things?                           Y N 
 
 
Intimate Partner Violence/Domestic Abuse Screen 
Are you in a relationship in which you have been physically hurt or threatened ?     Y N 
     Have you been in the past?                                                                                                                            Y N 
Are you in a relationship in which you have been verbally abused or threatened Y N 
     Have you been in the past?                                                                                                                            Y N 
Do you feel safe at home and / or your community?                                                                   Y N 
 
 
Tobacco Screen 
Do you smoke?           Y N 
      If so how much?   
Thinking about quitting?      Y N 
      If so you have a date set? Y N 
Referral to SCF Tobacco Cessation program ? Y N 
Do you chew tobacco?       Y N 
     If so how much?   
     Thinking of quitting? Y N 
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Appendix F: History of the UWC 
Originally patrol ships of the Navy provided medical to the community when they 
visited in the late 1870s.  The Coast guard began making some medical visits to the 
community beginning in 1897 (Fortuine, 1986).     
When civil government was established in Alaska in 1884, the Department of 
Education trained their teachers to in basic health care.  The Bureau of Education opened 
a small hospital on the island in 1926 and provided care to residents.  A new hospital was 
built in 1933 (Fortuine, 1986).  This hospital was destroyed during the Japanese attack on 
June 3, 1942 (National Park Service, no date).   
After the war, health care for Alaska Native residents was provided by the Indian 
Health Service who sent out physicians periodically.  The community comprised of non-
Natives and Alaska Natives in the late 1970s with support of the local tribe and financial 
support from the Alaska Area Indian Health Service.  The clinic was intended for all 
members of the community, Alaska Natives and all others.  However, over the years, 
discontent arose over the management of this clinic. 
The local tribe felt that the community clinic was not meeting their needs and was 
culturally unaware, and they were being treated as second class citizens compared to the 
workers coming in for the crab fisheries.  A small Community Health Aide clinic was 
started in 1986 in a small two room building.  The UWC was relocated to a new facility 
in 1996.  The new clinic was located on the second floor of a building, in which the local 
community health center clinic was located on the first floor.  At this time a nurse 
practitioner and/or physician assistant was added to the staff at UWC.       
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Administrative operations 
UWC is operated by an Alaska Native non-profit organization.  The parent 
organization is located in Anchorage and operates five clinics in the Pribilof islands and 
in the Western Aleutian islands.  Staff in the Anchorage office who also participated in 
IPC includes the Quality Improvement Coordinator and the Clinical Applications 
Coordinator.   
The parent organization and all its clinics are part of the Alaska Area Indian 
Health Service (IHS).  The IHS works with Alaska Native Tribes and Tribal 
organizations to provide health services to approximately 150,000 Alaska Natives.  There 
are 228 federally recognized tribes in Alaska.  The majority of tribes across the state have 
formed consortiums in order to maximize their ability to provide health care in their 
region.  A handful of tribes are single entity contractors.  These tribal organizations 
operate under the authority of the Indian Self-Determination and Education Assistance 
Act, PL 93-638.  This act allows tribes to direct and manage their own health care.  
Tribally managed hospitals are located in Anchorage, Barrow, Bethel, Dillingham, 
Kotzebue, Nome and Sitka.  There are 36 tribal health centers and 180 tribal Community 
Health Aide clinics across the state (ANMC, no date).  The Alaska Native Medical 
Center is the tertiary hospital for all Alaska Native health care facilities in the state.  The 
hospital is managed by a consortium of tribes from around the state, the Alaska Native 
Tribal Health Consortium.  The representatives to the consortium are appointed by their 
various tribes.    
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UWC’s funding comes from federal and state grants, and federal appropriation.  
UWC, via its parent agency, although not required to, provides data to the federal 
government such as patient encounter numbers and Government Reporting and 
Accountability Act (GPRA) data. 
The parent agency for UWC has a board of directors that oversees its operations.  
This board of directors is made up of individuals from the member communities that 
make up the organization.  Board members are elected or appointed by their respective 
tribe to represent their village.  Each board member serves a two year term, although 
many members have been re-appointed.  The board meets quarterly to review progress, 
challenges and to plan for the future. 
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Appendix G: Description of Clinic Personnel and Clinic Setting 
Clinic Personnel 
At the time of the collaborative, the UWC staff included three medical providers 
(two Community Health Aides, one nurse practitioner, and one physician’s assistant), one 
medical assistant, one patient accounts representative, one receptionist, one Community 
Wellness Advocate, and an administrator.  Credentialing for UWC providers is done by a 
non-profit tribally run agency associated with the referral hospital in Anchorage.  This 
sister agency regularly scheduled required orientation classes for providers new to 
Alaska.   The orientation was a weeklong and included introduction to the cultures of 
Alaska and the Alaska Native Health Care system and the various specialty clinics at the 
hospital and associated tribally run agencies.   
This same agency operated the primary care clinics (i.e., family medicine, 
obstetrics and gynecology, internal medicine, pediatrics and optometry) in a building 
across the street from the hospital.  These services required a referral by a UWC provider 
for eligible AI/AN patients.   
Clinic Service Delivery 
The UWC is 800 air miles from the nearest hospital in Anchorage.  The flight 
from Anchorage to the island is about 3 hours or more depending on the wind speed and 
wind direction.   A physician visited UWC for two days twice a year.   This physician, 
called the referral physician, is provided by one of the large tribally run non-profit health 
care corporations in Anchorage.  This physician was available for consultation via phone 
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or secure email regarding complex patients.  An optometrist and optician also from this 
large organization visited UWC yearly for a week.   
UWC also received a dental visit once a year by a dentist and hygienist from the 
large tribally operated health organization, for two weeks.   The emphasis for these visits 
was on children, as mandated by IHS policy.  If slots were open after the children’s 
appointments, then adults may make appointments.   
The clinic also received a yearly three day visit from the referral hospital diabetes 
care team, comprised of a diabetes nurse practitioner, nutritionist and foot care 
technician.  In the past the clinic also received twice yearly visits from a Women’s Health 
Care provider.  However, these services, considered a duplication of services, were 
discontinued by the tribally run organization in Anchorage.     
Pharmacy- Without a pharmacy on the island, the clinic had a Pick Point 
machine, similar to a vending machine to dispense medications.   Prescription 
medications are kept in a Pick Point machine.  In order to “drop” a medication, a script 
must be faxed to the referral hospital in Anchorage where it is reviewed by a pharmacist 
in village pharmacy (as opposed to outpatient pharmacy) for correct dose and any drug 
interactions.  The pharmacist then enters the script into their electronic health record 
which then sends a message to the printer at UWC located next to the Pick Point 
machine.  A label is printed out and the provider then scans the label and the medication 
drops out of the machine.  The provider then scans out the medication so that the 
inventory in the Pick Point machine is correct.   
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The Anchorage village pharmacy monitors medication levels and sends out 
replenishment meds as needed.  This process for processing a medication request can take 
anywhere from 10 minutes to over 30 minutes depending on how many scripts the 
pharmacy is handling.  Village pharmacy receives scripts from 50 different villages.  
Occasionally the Pick Point runs out of medications due to a sudden increase in certain 
infections or if the weather has been foggy for extended periods or if a local volcano has 
blown up and the mail cannot make it through.  Chronic medications are mailed directly 
to the patient by Village pharmacy. 
Laboratory - The Ukudigatunal Wellness Center (UWC) had only Clinical 
Laboratory Improvement Act (CLIA) and waived lab capability.  Waived tests offered at 
the clinic included: automated urine analysis, hemoglobin, and point of care (POC) 
glucose, sedimentation rate, rapid influenza, rapid strep, rapid trichamonis, urine 
pregnancy test, saliva alcohol, urine drug screen and Piccolo general chemistry.  All other 
labs went to the referral hospital in Anchorage by the USPS using express mail.  Results 
were generally back the next day or two days later depending on weather in the region.  
Frequently the ANMC lab was unable to run complete blood counts (CBC) because of 
mail delays and subsequent breakdown of the sample.  The ANMC lab faxed the results 
to the clinic on a secure fax line in the provider office.   
Diagnostic testing -UWC did not have x-ray or ultrasound.  If patients needed 
these tests, they went to the local Community Health Center (CHC).   The CHC, located 
in the same building as UWC, is on the first floor.  Contract Health Care funding covered 
the cost of studies done at the CHC.  The CHC had an ultrasound machine, but may or 
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may not be able to provide a qualified staff member to perform the study.  The CHC had 
no qualified ultrasound technician and providers did all studies.  No CT or MRI services 
were available on island.   
All other diagnostic testing (e.g., diagnostic ultrasound, stress tests, PET scans, 
bone density testing, etc.) must be done in Anchorage.   Patients who needed further 
specialty care or diagnostic testing not available on the island went to the Alaska Native 
Medical Center (ANMC) on a referral basis.   
Emergency Care - Major emergencies (e.g., heart attack, severe trauma, surgery 
cases) leave the island via medevac plane from Anchorage.  The average response time is 
four hours.  During the busy crab season, a medevac plane is assigned to stay in 
Unalaska.  However, it may not be available as the medevac company is often busy 
flying other ill or injured patients.  In extreme weather when the medevac plane cannot 
fly, the U.S. Coast Guard helicopter stationed in Kodiak responds. 
The Coast Guard takes the patient to the nearest open airport, usually Cold Bay, a 
1 ½ hour flight, where the medevac crew from Anchorage meets them.  The patient is 
then flown on into Anchorage.  This process can take up to 5 hours as the helicopter has 
to respond from Kodiak, and the travel must be approved and coordinated by a flight 
surgeon located in Seattle.  
Patients who do not have an emergent problem go to Anchorage by commercial 
air carrier.  Generally three to four commercial flights are available each day, depending 
on weather conditions and time of year.  Flight cancellations are frequent during the 
winter months due to high wind or poor visibility and in the summer due to fog.  One 
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year no flights were available for three weeks due to a nearby volcano spewing ash into 
the flight path.  The community air strip is too short for jet airliner, so commercial flights 
are via a Saab 340 double propeller plane, which carry up to 30 passengers. 
For those Anchorage Service Unit (a designation left over from the days when the 
area was administered by the Indian Health Service) patients who needed to make a trip 
to Anchorage for specialty visits or testing, the tribally run hospital paid round trip airfare 
from the village to Anchorage and provided housing.  Housing was either in quarters in a 
wing of the hospital building or in a hotel room.  The Anchorage Service Area included 
the Aleutian Chain and Pribilof Islands, Kodiak Island, the outer end of the Alaska 
Peninsula, the Kenai Peninsula and south central Alaska south of the Alaska Range 
(Fortuine, 1983).  If a patient required medical escort, ANMC also paid for the escort’s 
travel and housing.   The exception to the travel and housing were those patients who 
were either from out of state or from another Service Unit other than the Anchorage 
Service Unit.  In these cases the patient must either pay their own way to Anchorage or 
request travel from their home Service Unit or tribe.  This policy created hardships, 
because in some cases, tribes in the contiguous United States did not pay for any travel or 
care for their tribal members once they left the reservation.   
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Appendix H: Description of IPC Phases 
Phase 1 
IPC progressed through three phases.  In this first phase, seven activities took 
place. 
 Leadership Engagement.  IPC understood that organizations may progress 
through the various phases faster or slower than other organizations.  The progress also 
may not be linear, but rather cyclical in nature.  During this activity, IPC sought to 
involve leadership in the improvement process.  Identifying and encouraging a leadership 
sponsor involved first finding a person in upper management to commit to the process 
and support IPC activities.  Leadership roles included: setting a schedule for review of 
IPC progress, guiding the IPC process locally and communicating team progress to 
agency management and Tribal leaders.   
 Involving and Engaging the Community.  Community involvement goals 
included developing effective ways of listening to and communicating with the local 
community by means of surveys, PSAs, brochures, town meetings and listening circles.  
IPC teams were to have at least one community member as part of the local IPC 
improvement team.  The patient as a consumer had ideas and insights that the clinic staff 
had not considered.  Recruiting a community member was a difficult task to accomplish 
as the IPC team meets weekly and the four learning sessions were four days in length 
with three of them being held outside of the state.     
 Identifying the Microsystem.  The participating agency chose which part of the 
clinic setting to change or improve.  IPC recommended that an agency start small with 
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one part of their system.  This smaller piece was easier to handle and less complex than 
the whole.   
 Assess the microsystem.  One of the tools for this purpose was the “Green Book” 
assessment, a fairly extensive look at processes in the microsystem.  In addition, IPC 
members assessed their own abilities in terms of technology and the improvement 
process.   
 Developing an Aim Statement.  This living document changed as the IPC team 
improved the way it worked together.  The aim statement was to be measurable and have 
time limits.  It provided an initial orientation toward the activities of the improvement 
initiative and a description of the microsystem in the organization where the 
improvement would take place.  The aim statement was to include expected dates for key 
milestones and completion date. Also included was a reason for the effort, why it was 
important, and how it would benefit the organization, and described its impact on 
patients.  The aim also defined anticipated outcomes such as products, tools, deliverables 
or other success criteria.  The aim statement had specific objections with numerical goals.   
 Strategic Alignment.  The IPC aim and goals were to be in line with the agency’s 
strategic plan.  IPC supported the agency in their improvement process activities.  IPC 
was integral to the way the agency operates their clinical services.   
Identifying the Improvement Team Members.  The team members were active 
participants in the process and needed support for their participation by upper 
management.  At UWC the improvement team included a nurse practitioner, a 
physician’s assistant, two community health aides, a receptionist, a patient accounts 
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representative, the clinic administrator and the health director for the organization.  
Initially the clinical director, a nurse practitioner was in the leadership position, but the 
team realized that this role more appropriately belonged to the health director and 
administrator.  The nurse practitioner then participated as a medical team member, a 
closer fit to her role in the clinic.   
Phase 2 
IPC built upon concepts learned in Phase One.  Areas included in Phase 2 are the 
care team, communication plan, empanelment, clinical information system, access and 
continuity, transparence of improvement, the pre-visit, capacity for improvement and 
resources for improvement.   
Identification and Development of the Care team.  The care team consisted of 
primary care providers, case manager, and other ancillary providers.  This team worked 
on optimizing their roles and improving communication. The expectation was that each 
provider worked at the top of their training and certification.  In other words, the primary 
care provider was not expected to check in the patient and gather survey information.    
Developing a Communication Plan.  The IPC team reviewed communication 
plans identified in Phase 1 and sought to improve on the chosen methods.  The 
community was informed as to the progress or lack of progress in IPC activities through 
letters, meetings with the tribal council or in community events, such as health fairs or 
tribal events such as annual member meetings.   
Empanelment.  Empanelment refers to the process of placing a patient with a 
particular provider or care team.  The intended result of empanelment was to improve 
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continuity of care and improve outcomes because (1) The patient would be seeing the 
same provider each visit and (2) The care team would be familiar with the conditions and 
needs of their panel members.  The two UWC teams, named for local berries that 
residents would recognize (viz., the blueberry and the salmon berry teams), consisted of a 
nurse practitioner or physician’s assistant, and a community health aide.  Both teams 
shared the same case manager.   
Optimize the Clinical Information System (CIS).   The UWC used the IHS 
RPMS electronic health record (EHR) with reminders and prompts.  This system was 
similar to the system used by the Veteran’s Administration (VA).  The built in reminders 
varied depending on the patient’s age, gender, and health status.  For example, a 52 year 
old woman with diabetes might have reminders that she is due to have pap test, lipids 
assessment, tobacco assessment, functional assessment, and colon cancer screening.    
Another useful population management tool was iCare, developed by the IHS.  Teams 
followed their panels (group of patients) by logging into iCare and opening lists of patient 
groups such as those with hypertension, those of childbearing age, those with diabetes, 
etc.  On one screen the providers could see who was due for screenings, immunizations, 
lab work, etc.  The case manager worked with each team to send out letters to those 
patients who were due for preventive or disease related care.      
Access and Continuity of Care.  The definition involved patients seeing the 
same provider at each visit or as often as possible and tracked in IPC reporting.  Access 
to care involved the availability of the patient’s provider to their panel members.  The 
item reported to IPC particular to this activity was the third next available appointment.  
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The goal was to have same day access.  If a patient called for an appointment, were they 
able to see their provider the same day?  At UWC the average daily patient census was 
low, so the clinic seldom had problems with same day patient access to care.  Other 
organizations participating in IPC struggled with open access for their much larger 
patient populations. Making Quality Data Available.  The clinic communicated 
achievements of the collaborative by posting achievements to a wall in the clinic 
dedicated to IPC outcomes, mailings to all homes and providing reports at community 
meetings.  The aim was to have the IPC process be transparent. 
Develop Capacity and Resources for Improvement.  As members progressed 
through IPC, the expectation was to grow in their knowledge about improvement and the 
ability to apply knowledge from the various learning sessions and homework 
assignments.  The idea was to improve processes to eliminate waste and inefficiencies in 
care. 
Patient experience measures 
Patient experience measures included 5 categories: workforce, experience and 
efficiency, building relationships, access to care, and patient activation.  The workforce 
goal was to improve patient satisfaction.  Patients were asked to fill out a satisfaction 
survey when they come to the clinic.  The patients rated their experience on a 1-5 scale 
with the following ratings:  (a) strongly disagree, (b) disagree, (c) neither disagree or 
agree, (d) agree, (e) strongly agree.   
Questions included the following: 
1. I have a person who I think of as my personal provider. 
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2. It is very easy for me to get medical care when I need it. 
3. Most of the time, when I visit my doctor’s office, it is well organized and does not   
waste my time. 
4. The information given to me about my health problems is very good. 
5. I am sure that I can manage and control most of my health problems 
6. Overall the care I receive at the clinic meets my needs 
7. I am able to get the care I need and want- when I need and want it at the clinic. 
Tracking of the responses to the survey month by month enabled teams to identify 
improvement in decreasing scores.   Although patient satisfaction was a part of 
collaborative activities, evaluation of patient satisfaction was beyond the scope of this 
research project and not discussed. 
Phase 3 
This last phase of IPC had a focus on spread, efficiency, care management, patient self-
management and behavioral health integration.  A plan for spread to other parts of the 
clinic was to be developed and implemented.   With inefficiencies identified, PDSA 
cycles became useful in developing solutions for improvement.  Case managers and 
providers developed further skills in care management for their respective panels.  
Families and patients learned self-management of their health and health conditions. As 
well as becoming involved in decision making about care provided and provision of the 
services.  Staff members received training in brief action planning and collaborative goal 
setting in order to help families address health concerns.   
